Enantioselective NHC-catalyzed redox [4+2]-hetero-Diels-Alder reactions using α,β-unsaturated trichloromethyl ketones as amide equivalents by Attaba, Nassilia et al.
Enantioselective NHC-Catalyzed Redox [4+2]-hetero-Diels-
Alder Reactions using α,β-Unsaturated Trichloromethyl 
ketones as Amide Equivalents 
Nassilia Attaba, James E. Taylor, Alexandra M. Z. Slawin, and Andrew D. Smith* 
EaStCHEM, School of Chemistry, University of St Andrews, North Haugh, St Andrews,  
KY16 9ST, U.K. 
E-mail: ads10@st-andrews.ac.uk 
 
α,β-Unsaturated trichloromethyl ketones are suitable α,β-unsaturated amide and ester 
equivalents in N-heterocyclic carbene (NHC)-catalyzed redox hetero-Diels-Alder reactions 
with azolium enolates generated from α-aroyloxyaldehydes. The initially formed syn-
dihydropyranone products can be isolated, or can undergo ring-opening with benzylamine 
followed by aminolysis of the resulting CCl3 ketone to form a range of diamides with high 
diastereo- and enantioselectivity (up to >95:5 dr and >99% ee). 
  
Introduction 
N-Heterocyclic carbenes (NHCs) are valuable Lewis base organocatalysts that can react 
through a number of distinct catalytic activation modes.
1
 For example, azolium enolates are 
versatile intermediates that react with a range of electrophiles to form a wide variety of 
synthetically useful products. Azolium enolates have been accessed through reaction of 
NHCs with ketenes,
2
 α-reducible aldehydes,3-7 unfunctionalized aldehydes in the presence of 
an oxidant,
8
 and activated carboxylic acids or esters in the presence of a base.
9
 NHC-redox 
catalysis proceeding through addition of an NHC to an aldehyde bearing an α-reducible 
functional group is a particularly efficient method of forming azolium enolates.
10
 α-
Reducible aldehydes that have been used for this purpose include α-chloroaldehydes,3 enals,4 
α-aryloxyaldehydes,5 and formyl cyclopropanes6 (Scheme 1a).  
We have demonstrated that α-aroyloxyaldehydes are bench-stable azolium enolate 
precursors that can be utilized in a number of asymmetric NHC-catalyzed redox [4+2]-
cycloaddition reactions.
7
 For example, azolium enolates generated from α-aroyloxyaldehydes 
react with substituted trifluoromethyl ketones to form dihydropyranones with high levels of 
stereoselectivity (Scheme 1b).
7d 
The NHC-catalyzed redox reaction of α-aroyloxyaldehydes 
and N-aryl-N'-aroyldiazenes to synthesize enantiomerically enriched α-amino acid derivatives 
has also been explored.
7c 
While NHC-catalyzed asymmetric cycloadditions of azolium 
enolates with electron-deficient enones are widely reported, the use of α,β-unsaturated 
amides and esters remains a significant challenge due to the decreased electrophilicity of 
these substrates. This problem has been overcome in other Lewis based-catalyzed conjugate 
additions through the use of more reactive α,β-unsaturated amide/ester equivalents such as N-
acylpyrroles,
11
 2-acyl imidazoles,
12
 activated imides,
13
 α-ketophosphonates,14,15 and 
trichloromethyl  
 Scheme 1. Azolium enolate precursors for [4+2] hetero-Diels-Alder reactions 
 
ketones.
16,17
 However, the use of α,β-unsaturated amide and ester equivalents in NHC-
catalyzed cycloaddition reactions remains unexplored. 
Of particular relevance is the use of trichloromethyl ketones as carboxylic acid, ester and 
amide equivalents in processes that use the leaving group ability of the CCl3 ketone in 
haloform-type reactions.
18-20
 α,β-Unsaturated trichloromethyl ketones have previously been 
utilized as Michael acceptors in a small number of organocatalytic reactions.
16,17
 Zhao and 
co-workers reported the enantioselective epoxidation of α,β-unsaturated trichloromethyl 
ketones with tert-butylhydroperoxide (TBHP) catalyzed by diaryl prolinol 2.
16a
 
Trichloromethyl ketone 3 undergoes either aminolysis or alcoholysis to provide the 
corresponding amide or ester products without loss in enantioselectivity (Scheme 2a). 
Various bifunctional H-bonding/Lewis bases have also been used to catalyze the conjugate 
addition of nucleophiles including α-cyano ketones,16b α,β-unsaturated γ-butyrolactones,16c 
and azlactones
16d
 into α,β-unsaturated trichloromethyl ketones. We have reported the 
isothiourea-catalyzed Michael  
 
Scheme 2. Use of α,β-unsaturated trichloromethyl ketones as amide and ester 
equivalents 
 
addition-lactonization of substituted acetic acids and α,β-unsaturated trichloromethyl 
ketones.
17
 The initially formed anti-dihydropyranones 8 undergo ring-opening followed by 
alcoholysis of the CCl3 ketone with methanol to give a range of diesters 9 with high levels of 
diastereo- and enantioselectivity (Scheme 2b). This methodology is limited to the use of 
either 2-aryl or 2-alkenylacetic acids and gives preferential access to the anti-diastereoisomer 
of the dihydropyranone intermediates.  
Herein the use of α-aroyloxyaldehydes as azolium enolate precursors in [4+2] hetero-Diels-
Alder reactions with α,β-unsaturated trichloromethyl ketones is investigated, with the syn-
dihydropyranone products formed in good yields with high levels of diastereo- and 
enantioselectivity. Subsequent ring-opening followed by aminolysis of the CCl3 ketone gives 
access to a wide range of diamide products without loss of enantioselectivity (Scheme 2c). In 
one case, the sequential addition of two different nucleophiles led to the formation of a 
differentially substituted diacid derivative. The methodology described is complementary to 
the related isothiourea-catalyzed process as it allows access to 3-alkyl-substituted 
dihydropyranones and preferentially gives the syn-diastereoisomer of the products. 
Results and Discussion 
[4+2] Cycloaddition: Optimization and Generality.  
First, the NHC-catalyzed redox [4+2] hetero-Diels-Alder reaction between an azolium 
enolate generated from α-aroyloxyaldehyde 10 and α,β-unsaturated trichloromethyl ketone 1 
was studied. α-Aroyloxyaldehydes were prepared in one-step on a gram-scale from the parent 
aldehyde and 4-nitrobenzoic acid under oxidative conditions using a modified procedure of 
that described by Ishihara and co-workers.
21
 Trichloromethyl ketones were prepared on a 
gram-scale using a two-step procedure first reported by Corey and co-workers starting from 
the corresponding α,β-unsaturated aldehyde and can be stored for a number of months 
without decomposition.
22
 Initial studies found that α-aroyloxyaldehyde 10 reacts with 
trichloromethyl ketone 1 using 10 mol% triazolium NHC precatalyst 11 and triethylamine in 
THF at room temperature, giving dihydropyranone 12 in 57% yield and >95:5 dr, with the 
major syn-diastereoisomer formed in excellent >99% ee (Table 1, entry 1).
23
 The reaction 
proceeds in a number of different solvents, with CH2Cl2 giving dihydropyranone 12 in an 
improved 67% yield without compromising the stereoselectivity (Table 1, entries 2-4). 
Lowering the catalyst loading to 5 mol% gave comparable results (Table 1, entry 5), however 
further decreases in the amount of catalyst led to a significant reduction in isolated yield. 
Finally, performing  
 
 
Table 1. Reaction optimization
a
 
  
Entry Solvent 11 (mol%) t / h dr
b
 Yield (%) ee (%)
c
 
1 THF 10 5 >95:5 57 >99 
2 Et2O 10 1.5 >95:5 55 >99 
3 PhMe 10 1.5 >95:5 55 >99 
4 CH2Cl2 10 1 >95:5 67 >99 
5 CH2Cl2 5 3.5 >95:5 66 >99 
6
d
 CH2Cl2 5 3.5 >95:5 84 >99 
a
Reactions performed on 0.2 mmol scale. 
b
Determined by analysis of crude 
1
H NMR spectra. 
c
Determined by 
chiral HPLC analysis. 
d
Reaction performed on a 1.2 mmol scale. 
 
the reaction on a larger scale (1.2 mmol) gave syn-dihydropyranone 12 in 84% yield as a 
single diastereoisomer in >99% ee (Table 1, entry 6). 
The scope and generality of this procedure was studied through variation of the substituents 
on both the α-aroyloxyaldehyde and trichloromethyl ketone components (Table 2). A range 
of α-aroyloxyaldehyde substituents was tolerated under the previously optimized reaction 
conditions, forming functionalized syn-dihydropyranones 12-19 with excellent levels of 
diastereo- and enantioselectivity. A higher catalyst loading (10 mol% 11) was required to 
form dihydropyranones 14 and 15, as lower levels of diastereoselectivity were obtained over 
extended reaction times with a lower catalyst loading. For example, dihydropyranone 14 was 
formed in 65:35 dr after 48 hours under the standard reaction conditions using 5 mol% 11, 
with both diastereoisomers formed with high enantioselectivity (98% eesyn, >99% eeanti). 
Increasing 
 
Table 2. Use of trichloromethyl ketones in NHC-redox catalyzed [4+2] hetero-Diels-
Alder reactions 
 
Product 
Yield
a
 (time) 
dr
b
 
ee
c
 
Product 
Yield
a
 (time) 
dr
b
 
ee
c
 
 
a
Isolated yield of major syn-diastereoisomer. 
b
Determined by analysis of crude 
1
H NMR spectra. 
c
Determined 
by chiral HPLC analysis. 
d
Reaction performed using 10 mol% 11. 
e
Isolated as a mixture of diastereoisomers. 
f
ee 
could not be determined by either chiral HPLC or chiral GC analysis. 
 
the catalyst loading to 10 mol% allowed dihydropyranone 14 to be formed in 90:10 dr, with 
the major syn-diastereoisomer isolated in 60% yield and 99% ee. Similarly, dihydropyranone 
15 was formed in 90:10 dr after 26 hours using 5 mol% 11, whereas increasing the catalyst 
loading to 10 mol% allowed a single diastereoisomer to be isolated in 65% yield after 4 hours 
in >99% ee. Within the trichloromethyl ketone, β-aryl groups containing electron-donating 
(4-MeOC6H4) and electron-withdrawing halogen (4-BrC6H4) substituents were well tolerated, 
forming syn-dihydropyranones 17 and 18 as single diastereoisomers in excellent yields and 
>99% ee. However, β-alkyl substitution was less well tolerated, forming syn-
dihydropyranone 19 in a low 26% yield despite using 10 mol% 11 for an extended reaction 
time, although the diastereo- and enantioselectivity remained high. 
To investigate the drop in diastereoselectivity observed for the reactions with some of the 
α-aroyloxyaldehyde substituents an epimerization experiment was performed. Treating 
isolated syn-dihydropyranone 14 (90:10 dr, 99% ee) with triethylamine in CD2Cl2 at room 
temperature resulted in a mixture of syn-14 and anti-20 (67:33 dr), with both 
diastereoisomers obtained in >99% ee (Scheme 3). This is consistent with a base-promoted 
epimerization of the C(3) stereocenter, which accounts for the loss in diastereoselectivity in 
reactions that required extended reaction times upon changing the α-aroyloxyaldehyde 
component. 
Scheme 3. Base-promoted epimerization of 14 
 
Trichloromethyl ketones as Ester and Amide Equivalents.  
Next, the synthetic utility of the trichloromethyl substituent as an ester/amide equivalent 
was examined. It was hoped that treating the crude syn-dihydropyranone products with an 
excess of a suitable nucleophile (alcohol or amine) would lead to ring-opening followed by 
alcoholysis/aminolysis of the CCl3 ketone. Pleasingly, adding an excess of benzylamine to 
crude syn-dihydropyranone 12 led to formation of the expected diamide 21 in excellent 85% 
yield as a single diastereoisomer in >99% ee (Scheme 4a). In contrast, treating crude syn-
dihydropyranone 12 with DMAP (20 mol%) and an excess of methanol gave a mixture of 
trichloroketoester 22 and diester 23, with both formed with high levels of  
 
Scheme 4. Use of trichloromethyl ketones as ester and amide equivalents 
 
stereoselectivity (Scheme 4b).
24
 The observation that only partial alcoholysis of the CCl3 
ketone had occurred led to the possibility of a sequential ring-opening and CCl3 ketone 
displacement using two different nucleophiles. Firstly, benzyl alcohol and DMAP (20 mol%) 
were used to ring-open the initial syn-dihydropyranone product with subsequent addition of 
benzylamine (1.2 eq) leading to aminolysis of the CCl3 ketone to give γ-ester amide 24 in 
32% yield and >99% ee over the three reaction steps (Scheme 4c). This reactivity is in 
contrast to the use of α-keto-β,γ-unsaturated phosphonates as ester/amide equivalents in 
related reactions where both ring-opening and either alcoholysis or aminolysis of the 
phosphate group occurs rapidly and therefore differential substitution is not possible.
14d
 
Moreover, dihydropyranones formed from related reactions using α,β-unsaturated 
trifluoromethyl ketones undergo ring-opening with no alcoholysis / aminolysis of the 
trifluoromethyl ketone observed.
7d
 The utility of trichloromethyl ketones as amide 
equivalents in this NHC-catalyzed redox [4+2] cycloaddition process was  
Table 3. NHC-redox catalyzed [4+2] cycloaddition followed by ring-opening and 
aminolysis 
 
Product 
Yield
a
 (time) 
dr
b
 
ee
c
 
Product 
Yield
a
 (time) 
dr
b
 
ee
c
 
 
a
Isolated yield of major syn-diastereoisomer. 
b
Determined by analysis of crude 
1
H NMR spectra. 
c
Determined 
by chiral HPLC analysis. 
d
Reaction performed using 10 mol% 11. 
e
ee could not be determined by either chiral 
HPLC or chiral GC analysis. 
further assessed using a range of substituted α-aroyloxyaldehydes and α,β-unsaturated 
trichloromethyl ketones (Table 3). The cycloaddition reactions were performed under the 
previously optimized conditions and the initially formed syn-dihydropyranones underwent 
ring-opening and aminolysis with benzylamine. The resulting diamide products 21, 25-33 
were conveniently purified by trituration and did not require column chromatography.
25 
A number of substituted α-aroyloxyaldehydes was successfully applied in this process, 
forming diamides 21, 25-27 in high yields as single diastereoisomers and in excellent ee. 
Benzyl substituted diamide 27 was formed with lower diastereoselectivity (80:20 dr), which 
is consistent with base-promoted epimerization of dihydropyranone 16 under the reaction 
conditions (cf. Table 2). A wide range of substituted trichloromethyl ketone derivatives was 
also tolerated, including those containing electron-donating aryl (4-MeOC6H4), electron-
withdrawing aryl (2-NO2C6H4) and heteroaromatic substituents, forming functionalized 
diamides 28-32 in good yields with excellent levels of stereocontrol. As observed previously, 
the incorporation of a β-alkyl substituent led to a significantly lower yield of diamide 33. The 
relative and absolute configuration of diamide 28 was confirmed by X-ray crystallographic 
analysis,
23
 with the stereochemistry of all other products assigned by analogy. 
Proposed Mechanism.  
The proposed catalytic cycle starts with nucleophilic addition of the free NHC into the α-
aroyloxyaldehyde, with the resulting adduct 34 likely to be the resting state of the catalyst 
(Scheme 5).
7b,26
 Deprotonation forms the Breslow intermediate, which can eliminate 4-
nitrobenzoate to form an enol that undergoes further deprotonation into the key azolium 
enolate intermediate. Consistent with the work of Bode and co-workers,
27
 the azolium enolate 
is thought to undergo an asynchronous endo-hetero-Diels-Alder reaction with the α,β-
unsaturated trichloromethyl ketone. Elimination of the catalyst generates the syn-
dihydropyranone product, which can undergo ring-opening using benzylamine or an alcohol, 
with aminolysis of the resulting trichloromethyl ketone proceeding at a relatively slower rate.  
Scheme 5. Proposed mechanism 
 Conclusion 
α,β-Unsaturated trichloromethyl ketones act as amide equivalents in NHC-catalyzed redox 
[4+2] hetero-Diels-Alder reactions with azolium enolates generated from bench-stable α-
aroyloxyaldehydes. The initially formed syn-dihydropyranones can be isolated in good yields 
with excellent levels of diastereo- and enantioselectivity. The dihydropyranone products 
undergo facile ring-opening with benzylamine and further aminolysis of the resulting CCl3 
ketone leads to the formation of diamides. A wide range of both α-aroyloxyaldehydes and 
α,β-unsaturated trichloromethyl ketones can be utilized in this process, generating 
functionalized diamide products in high yields with excellent levels of stereoselectivity.  
Experimental Section 
General: All reactions were performed in flame dried glassware using anhydrous solvents. 
All reagents were obtained from commercial sources and were used without further 
purification. Room temperature (rt) refers to 2025 °C, with temperatures of 0 °C and 10 °C 
obtained using ice/water and ice/water/salt baths, respectively. Optical rotations were 
recorded with a path length of 1 dm and concentrations, c, are quoted in g/100 mL. All chiral 
HPLC traces were compared with an authentic racemic trace prepared using (rac)-11. Infra-
red spectra were recorded as thin films using an ATR accessory. 
1
H NMR spectra were 
acquired at either 300, 400, 500 or 700 MHz, 
13
C{
1
H} NMR spectra were acquired at either 
75, 101 or 126 MHz, and 
19
F{
1
H} NMR spectra were acquired at either 282, 376, or 471 
MHz. Chemical shifts are quoted in parts per million (ppm) relative to the residual solvent 
peak, coupling constants, J, are quoted in Hertz (Hz). NMR peak assignments were 
confirmed using 2D 
1
H COSY, 2D 
1
H NOESY, 2D 
1
H-
13
C HMBC and 2D 
1
H-
13
C HSQC 
where necessary. Mass spectrometry (m/z, HRMS) data were acquired using either 
atmospheric pressure chemical ionisation (APCI) or nanospray ionisation (NSI) using a TOF 
mass analyser.  
NHC-precatalyst 11 was synthesized on a gram-scale according to a literature procedure.
28
 
Commercially available reagents were used as supplied without further purification unless 
stated otherwise.  
Preparation of -Aroyloxyaldehydes 
1-Oxopropan-2-yl 4-nitrobenzoate (10). Prepared according to a previously reported 
procedure as a beige solid with data in accordance with literature.
7b
 mp 74–76 °C {lit.7b mp 
78–80 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.59 (3H, d, J 7.2, CH3), 5.39 (1H, q, J 7.2, 
CHCH3), 8.24–8.37 (4H, m, 4-NO2ArH), 9.67 (1H, s, CHO). 
1-Oxo-3-phenylpropan-2-yl 4-nitrobenzoate. Prepared according to a previously reported 
procedure as a beige solid with data in accordance with literature.
7b 
mp 91–93 °C {lit.7b mp 
85–86 °C}; 1H NMR (300 MHz, CDCl3) δH: 3.22 (1H, dd, J 14.5, 8.4, CH
A
H
B
), 3.35 (1H, dd, 
J 14.5, 5.0, CH
A
H
B
), 5.52 (1H, dd, J 8.3, 5.0, CHCH2), 7.27–7.38 (4H, m, ArH), 8.15–8.23 
(2H, m, 4-NO2ArH), 8.26–8.35 (2H, m, 4-NO2ArH), 9.68 (1H, s, CHO). 
4-(1,3-Dioxoisoindolin-2-yl)-1-oxobutan-2-yl 4-nitrobenzoate. Phthalic anhydride (4.5 g, 
34 mmol, 1.0 eq) and 4-aminobutan-1-ol (3.1 mL, 34 mmol, 1.0 eq) were heated in toluene 
(100 mL) at reflux under Dean-Stark conditions for 3 h. The reaction mixture was allowed to 
cool to rt before being concentrated to give 2-(4-hydroxybutyl)-2,3-dihydro-1H-isoindole-
1,3-dione as a pale yellow solid (7.0 g, 32 mmol, 95%), with spectroscopic data in 
accordance with the literature;
29
 mp 4749 °C {lit.29mp 4849 °C}; 1H NMR (500 MHz, 
CDCl3) δH: 1.64 (2H, p, J 6.6, NCH2CH2), 1.80 (2H, p, J 7.3, N(CH2)2CH2), 3.71 (2H, t, J 
6.4, NCH2), 3.76 (2H, t, J 7.2, N(CH2)3CH2), 7.73 (2H, dd, J 5.5, 3.0, ArH), 7.86 (2H, dd, J 
5.4, 3.1, ArH). 
A solution of oxalyl chloride (2.3 mL, 27 mmol, 2.0 eq) in CH2Cl2 (50 mL) was cooled to 
78 °C before a solution of DMSO (2.14 mL, 30 mmol, 2.2 eq) in CH2Cl2 (10 mL) was 
added dropwise. After stirring for 15 min a solution of 2-(4-hydroxybutyl)-2,3-dihydro-1H-
isoindole-1,3-dione (3.0 g, 14 mmol, 1.0 eq) in CH2Cl2 (10 mL) was added dropwise. The 
reaction mixture was stirred for 15 min before Et3N (5.7 mL, 41 mmol, 3.0 eq) was added 
dropwise. The reaction was stirred for 5 min before warming to rt and stirring for an 
additional 15 min. The reaction was diluted with CH2Cl2, washed with 1 M HCl and brine. 
The organic layer was dried over Na2SO4, filtered and concentrated to give the crude product 
that was purified by flash silica column chromatography (70:30 petrol : EtOAc) to give 4-
(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)butanal as a white solid (1.7 g, 7.9 mmol, 57%), 
with spectroscopic data in accordance with the literature;
30
 mp 6668 °C; {lit.30 mp 7274 
°C}; 
1
H NMR (500 MHz, CDCl3) δH: 2.04 (2H, p, J 7.0, NCH2CH2), 2.51–2.62 (2H, m, 
N(CH2)2CH2), 3.73–3.80 (2H, m, NCH2), 7.74 (2H, dd, J 5.4, 3.1, NCOArH), 7.87 (2H, dd, J 
5.5, 3.0, ArH), 9.79 (1H, t, J 1.1, CHO). 
From an adapted procedure of Ishihara et al.,
21
 4-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-
yl)butanal (1.7 g, 7.9 mmol), 4-nitrobenzoic acid (2.0 g, 12 mmol), n-Bu4NI (0.58 g, 1.6 
mmol) and piperidine (78 μL, 0.79 mmol) were dissolved in EtOAc (40 mL) and t-BuOOH 
(56 M solution in decane, 1.57 mL) was added. The reaction mixture was heated at 50 °C for 
5 h before being cooled to rt and quenched with Na2SO4. The phases were separated and the 
aqueous extracted with EtOAc (× 2). The combined organics were washed with sat. aq. 
NaHCO3 (× 2) and brine (× 2) before being dried over MgSO4, filtered and concentrated. The 
crude product was purified by flash silica column chromatography (70:30 petrol : EtOAc) to 
give 4-(1,3-dioxoisoindolin-2-yl)-1-oxobutan-2-yl 4-nitrobenzoate as a pale orange solid (1.9 
g, 4.8 mmol, 62%); mp 3841 °C; νmax (film) 1705 (br, C=O); 
1
H NMR (300 MHz, CDCl3) 
δH: 2.26–2.38 (1H, m, NCH2CH
A
H
B
), 2.40–2.51 (1H, m, NCH2CH
A
H
B
), 3.95 (2H, t, J 6.5, 
NCH2), 5.35 (1H, dd, J 9.3, 3.7, CHCHO), 7.65–7.84 (4H, m, ArH), 8.19–8.26 (4H, m, 4-
NO2ArH), 9.62 (1H, s, CHO); 
13
C{
1
H} NMR (75 MHz, CDCl3) δC: 27.4 (NCH2CH2), 34.2 
(NCH2), 77.4 (CHCHO), 123.5 (NCOArC(2)), 123.7 (ArC(2)), 131.1 (ArC(3)), 131.9 
(NCOArC(1)), 134.1 (ArC(1)), 134.4 (NCOArC(1)), 150.9 (CO2), 164.2 (ArC(4)), 168.2 
(NCOAr), 196.3 (CHO); HRMS (APCI
+
) C19H15N2O7 [M+H]
+
 found 383.0874, requires 
383.0874 (+0.1 ppm). 
1-(4-Methoxyphenyl)-3-oxopropan-2-yl 4-nitrobenzoate. Prepared according to a 
previously reported procedure as a viscous yellow oil with data in accordance with the 
literature.
7c 1
H NMR (300 MHz, CDCl3) δH: 3.17 (1H, dd, J 14.6, 8.1, C(1)H
A
H
B
), 3.29 (1H, 
dd, J 14.6, 5.1, C(1)H
A
H
B
), 3.78 (3H, s, ArOCH3), 5.47 (1H, dd, J 8.0, 5.0, C(2)H), 6.85 (2H, 
d, J 8.6, MeOArC(3,5)H), 7.19 (2H, d, J 8.6, MeOArC(2,6)H), 8.20 (2H, d, J 8.6, 4-
NO2ArC(2,6)H), 8.31 (2H, d, J 8.6, 4-NO2ArC(3,5)H), 9.66 (1H, s, CHO). 
1-(Benzo[d][1,3]dioxol-5-yl)-3-oxopropan-2-yl 4-nitrobenzoate. Prepared according to a 
previously reported procedure as a viscous orange oil with data in accordance with the 
literature.
7c 1
H NMR (300 MHz, CDCl3) δH: 3.14 (1H, dd, J 14.6, 8.2, C(1)H
A
H
B
), 3.26 (1H, 
dd, J 14.6, 5.0, C(1)H
A
H
B
), 5.46 (1H, dd, J 8.1, 5.0, C(2)H), 5.94 (2H, s, OCH2O), 6.69–6.77 
(3H, m, ArCH), 8.21 (2H, d, J 8.9, 4-NO2ArC(2,6)H), 8.32 (2H, d, J 8.9, 4-NO2ArC(3,5)H), 
9.66 (1H, s, CHO). 
1-Oxohexan-2-yl 4-nitrobenzoate. Prepared according to a previously reported procedure as 
a yellow oil with data in accordance with literature.
7b
 
1
H NMR (400 MHz, CDCl3) δH: 0.95 
(3H, t, J 7.2, CH3), 1.37–1.45 (2H, m, CH2), 1.45–1.54 (2H, m, CH2), 1.93 (2H, ddd, J 15.5, 
14.6, 8.5, CH2), 5.31 (1H, dd, J 8.3, 4.7, CH)), 8.25–8.35 (4H, m, 4-NO2ArH), 9.64 (1H, d, J 
0.5, CHO). 
Preparation of α,β-Unsaturated Trichloromethyl ketones 
(E)-1,1,1-Trichloro-4-phenylbut-3-en-2-one (1). Prepared according to a previously 
reported procedure as a white solid with data in accordance with literature.
17
 mp 57–59 °C 
{lit.
17 
mp 59 °C}; 
1
H NMR (300 MHz, CDCl3) δH: 7.34 (1H, d, J 15.6, C(3)H), 7.41–7.52 
(3H, m, ArH), 7.61–7.70 (2H, m, ArH), 8.01 (1H, d, J 15.6, C(4)H).  
(E)-1,1,1-Trichloro-4-(4-methoxyphenyl)but-3-en-2-one. Prepared according to a 
previously reported procedure as a white solid with data in accordance with literature.
17
 mp 
98–100 °C {lit.17 mp 98–100 °C}; 1H NMR (400 MHz, CDCl3) δH: 3.87 (3H, s, OCH3), 6.92–
6.99 (2H, m, ArH), 7.21 (1H, d, J 15.6, C(3)H), 7.58–7.65 (2H, m, ArH), 7.97 (1H, d, J 15.5, 
C(4)H). 
(E)-4-(4-Bromophenyl)-1,1,1-trichlorobut-3-en-2-one. From an adapted procedure of Patil 
and Singh,
31
 reactivated MnO2 (2.0 g, 23.mmol)
32
 was added portion-wise to a solution of 
(E)-3-(4-bromophenyl)prop-2-en-1-ol (491 mg, 2.3 mmol) and in CH2Cl2 (9.8 mL) and 
stirred at rt for 3.5 h. The mixture was filtered through Celite
®
 and concentrated to give (E)-
3-(4-bromophenyl)acrylaldehyde (413 mg, 88%) as a brown solid that was used without 
further purification with data in accordance with literature.
33
 
1
H NMR (300 MHz, CDCl3) δH: 
6.70 (1H, dd, J 16.0, 7.6, C(2)H), 7.43–7.38 (2H, m, ArH), 7.48–7.43 (1H, m, C(3)H), 7.62–
7.54 (2H, m, ArH), 9.71 (1H, d, J 7.6, CHO).  
Following the procedure by Zhao et al.,
16a
 (E)-3-(4-bromophenyl)acrylaldehyde (387 mg, 
1.83 mmol, 1.0 eq) was added to a solution of CHCl3 (293 μL, 3.66 mmol, 2.0 eq) in DMF 
(1.3 mL) at rt. The reaction mixture was stirred at rt for 20 min then cooled to 0 °C before a 
solution of KOH (205 mg, 3.66 mmol, 2.0 eq) in EtOH (660 µL) was added dropwise. The 
reaction was stirred at 0 °C for 2 h. The reaction mixture was acidified with 1 M HCl and 
extracted with EtOAc (× 2). The combined organics were washed with water (× 2) and brine 
(× 3) before being dried over MgSO4, filtered and concentrated to give ((E)-4-(4-
bromophenyl)-1,1,1-trichlorobut-3-en-2-ol (562 mg, 93%) as a brown oil that was used 
without further purification. 
1
H NMR (300 MHz, CDCl3) δH: 4.76 (1H, dd, J 5.9, 1.3, C(1)H), 
6.37 (1H, dd, J 15.9, 5.9, C(2)H), 6.85 (1H, br d, C(3)H), 7.27–7.35 (2H, m, ArH), 7.43–7.52 
(2H, m, ArH).  
Following the procedure described by Evans et al.,
34
 ((E)-4-(4-bromophenyl)-1,1,1-
trichlorobut-3-en-2-ol (562 mg, 1.70 mmol, 1.0 eq) and distilled Et3N (711 μL, 5.10 mmol, 
3.0 eq) were dissolved in anhydrous CH2Cl2 (13.5 mL). A solution of sulfur trioxide pyridine 
complex (812 mg, 5.10 mmol, 3.0 eq) in distilled DMSO (2.7 mL) was added dropwise at 0 
°C. The reaction mixture was stirred at 0 °C for 24 h before adding again sulfur trioxide 
pyridine complex (812 mg, 5.10 mmol, 3.0 eq). The reaction mixture was stirred at rt for 48 h 
before being diluted in water (10 mL), extracted with Et2O (2 × 20 mL) and washed 
successively with sat. aq. CuSO4 (20 mL), sat. aq. NaHCO3 (2 × 20 mL) and brine (2 × 20 
mL). The organic layer was dried over MgSO4, filtered and concentrated to give (E)-4-(4-
bromophenyl)-1,1,1-trichlorobut-3-en-2-one (583 mg, quant.) as a brown solid that was used 
without further purification with data in accordance with literature.
16a
 
1
H NMR (300 MHz, 
CDCl3) δH: 7.32 (1H, d, J 15.7, C(2)H), 7.48–7.65 (4H, m, ArH), 7.93 (1H, d, J 15.6, C(3)H). 
(E)-1,1,1-Trichloronon-3-en-2-one. Prepared according to a previously reported procedure 
as a yellow oil with data in accordance with literature.
17 1
H NMR (400 MHz, CDCl3) δH: 
0.87–0.93 (3H, m, CH3), 1.28–1.38 (4H, m, CH2 × 2), 1.48–1.56 (2H, m, C(6)H2), 2.34 (2H, 
app qd, J 7.2, 1.6, C(5)H2), 6.73 (1H, dt, J 15.3, 1.6, C(3)H), 7.34 (1H, dt, J 15.4, 7.0, 
C(4)H). 
(E)-1,1,1-Trichloro-4-(4-fluorophenyl)but-3-en-2-one. Prepared according to a previously 
reported procedure as a white solid with data in accordance with literature.
17
 mp 66–64 °C 
{lit.
16a 
mp 60–62 °C}; 1H NMR (500 MHz, CDCl3) δH: 7.10–7.18 (2H, m, ArC(3,5)H), 7.26 
(1H, d, J 15.6, C(3)H), 7.62–7.70 (2H, m, ArC(2,6)H), 7.97 (1H, d, J 15.6, C(4)H); 19F{1H} 
NMR (471 MHz, CDCl3) δF: −106.65(ArC(4)F). 
(E)-1,1,1-Trichloro-4-(2-nitrophenyl)but-3-en-2-one. Prepared according to a previously 
reported procedure as a white solid with data in accordance with literature.
17
 mp 56–58 °C 
{lit.
17
 mp 56–58 °C}; 1H NMR (400 MHz, CDCl3) δH: 7.24 (1H, d, J 15.5, C(3)H), 7.60–7.66 
(1H, m, ArCH), 7.70–7.75 (2H, m, ArCH), 8.10–8.12 (1H, m, ArC(3)H), 8.43 (1H, d, J 15.5, 
C(4)H). 
(E)-1,1,1-Trichloro-4-(furan-2-yl)but-3-en-2-one. Prepared according to a previously 
reported procedure as a white solid with data in accordance with literature.
17
 mp 40–42 °C 
{lit.
16a
 mp 42–44 °C}; 1H NMR(400 MHz, CDCl3) δH: 6.56 (1H, dd, J 3.5, 1.8, ArC(4)H), 
6.84 (1H, d, J 3.6, ArC(3)H), 7.21 (1H, d, J 15.3, C(3)H), 7.57–7.60 (1H, m, ArC(5)H), 7.73 
(1H, d, J 15.3, C(4)H). 
  
General Procedure for the NHC-catalyzed Redox Synthesis of syn-Dihydropyranones: 
The appropriate α-aroyloxyaldehyde (0.30 mmol, 1.5 eq), the appropriate 
trichloromethylketone (0.20 mmol, 1.0 eq) and NHC precatalyst 11 (0.010 mmol, 5 mol% or 
0.020 mmol, 10 mol%) were dissolved in anhydrous CH2Cl2 (2.7 mL). Et3N (0.30 mmol, 1.5 
eq) was added and the reaction mixture was stirred at rt until complete by TLC analysis. The 
mixture was diluted in EtOAc (10 mL) and washed with sodium bisulfite aq. 40% (10 mL) 
and brine (10 mL). The organic layer was dried over MgSO4, filtered and concentrated to 
give the crude product that was purified by flash silica column chromatography. 
(3S,4S)-3-Methyl-4-phenyl-6-(trichloromethyl)-3,4-dihydro-2H-pyran-2-one (12). 
Following the general procedure, 1-oxopropan-2-yl 4-nitrobenzoate 10 (402 mg, 1.80 mmol), 
(E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 1 (300 mg, 1.20 mmol), NHC precatalyst 11 (22.1 
mg, 0.060 mmol) and Et3N (251 µL, 1.80 mmol) in anhydrous CH2Cl2 (16.2 mL) at rt for 3.5 
h gave a crude brown solid (˃95:5 dr) that was purified by flash silica column 
chromatography (90:10 hexane : EtOAc) to give the title compound (307 mg, 84%) as a 
white solid. mp 142–145 °C; [α]D
20 +237.5 (c 0.41, CH2Cl2); Chiral HPLC AD-H (95:5 
hexane : IPA, flow rate 1.0 mL·min
-1
, 220 nm, 30 °C) tR major: 5.9- min, tR minor: 7.1 min, 
˃99% ee; νmax (film, cm
-1
) 1776 (C=O), 1674 (C=C), 1601 (Ar C=C), 1493 (Ar C=C), 1454 
(Ar C=C);
 1
H
 
NMR (400 MHz, CDCl3) δH: 1.06 (3H, d, J 6.9, CH3), 3.08 (1H, p, J 6.9, 
C(3)H), 3.75 (1H, t, J 6.8, C(4)H), 6.42 (1H, d, J 6.5, C(5)H), 7.04–7.14 (2H, m, C(4)ArCH), 
7.28–7.39 (3H, m, C(4)ArCH); 13C{1H} NMR (126 MHz, CDCl3) δC: 12.1 (CH3), 38.2 
(C(3)), 42.4 (C(4)), 90.1 (CCl3), 108.0 (C(5)), 128.1 (C(4)ArCH), 128.3 (C(4)ArCH), 129.2 
(C(4)ArCH), 135.8 (C(4)ArC(1)), 149.5 (C(6)), 168.6 (C(2)); m/z (APCI
+
) 307 [(M(
35
Cl2,
 
37
Cl)+H]
+
, 100%), 305 [(M(
35
Cl3)+H]
+
, 98%); HRMS (APCI
+
) C13H12
35
Cl3O2 [M+H]
+
 found 
304.9903, requires 304.9897 (+1.5 ppm). 
(3S,4S)-3-Benzyl-4-phenyl-6-(trichloromethyl)-3,4-dihydro-2H-pyran-2-one (13). 
Following the general procedure, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (90 mg, 0.30 
mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 1 (50 mg, 0.20 mmol), NHC precatalyst 
11 (3.7 mg, 0.010 mmol) and Et3N (42 µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt 
for 4 h gave a brown oil (˃95:5 dr) that was purified by column chromatography (90:10 
petrol : EtOAc) to give the title compound (62 mg, 95% pure, 81%) as a light red oil. [α]D
20  
+167.7 (c 0.43, CH2Cl2); Chiral HPLC AS-H (99:1 hexane : IPA, flow rate 0.5 mL·min
-1
, 211 
nm, 30 °C) tR minor: 16.6 min, tR major: 19.2 min, ˃99% ee; νmax (film, cm
-1
) 1780 (C=O), 
1670 (C=C), 1603 (Ar C=C), 1495 (Ar C=C), 1454 (Ar C=C); 
1
H NMR (400 MHz, CDCl3) 
δH: 2.35–2.46 (1H, m, C(3)CH
A
H
B
), 3.21–3.34 (2H, m, C(3)CHAHB and C(3)H), 3.65–3.72 
(1H, m, C(4)H), 6.37 (1H, d, J 6.8, C(5)H), 7.01–7.08 (2H, m, ArH), 7.11 (2H, m, ArH), 
7.29–7.41 (6H, m, ArH); 13C{1H} (101 MHz, CDCl3) δC: 32.0 (CH2), 39.9 (C(4)), 44.8 
(C(3)), 90.1 (CCl3), 108.6 (C(5)), 126.8 (ArCH), 128.3 (ArCH × 2), 128.4 (ArCH), 128.7 
(ArCH × 2), 128.9 (ArCH × 2), 129.3 (ArCH × 2), 135.9 (C(3)ArC(1)), 137.8 
(C(2)CH2ArC(1)), 149.1 (C(6)), 167.8 (C(2)); m/z (APCI
+
) 381 ([M(
35
Cl3)+H]
+
, 100%); 
HRMS (APCI
+
) C19H16O2
35
Cl3 [M+H]
+
 found 381.0204, requires 381.0210 (–1.7 ppm). 
2-(2-((3S,4S)-2-Oxo-4-phenyl-6-(trichloromethyl)-3,4-dihydro-2H-pyran-3-yl)ethyl)iso-
indoline-1,3-dione (14). Following the general procedure 4-(1,3-dioxoisoindolin-2-yl)-1-
oxobutan-2-yl 4-nitrobenzoate (115 mg, 0.30 mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-
one 1 (50 mg, 0.20 mmol), NHC precatalyst 11 (7.4 mg, 0.020 mmol, 10 mol%) and Et3N (42 
µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 7 h gave a brown solid (90:10 dr) that 
was purified by column chromatography (90:10 petrol : EtOAc) to give the title compound 
(55 mg, 60%) as a white solid. mp 132 °C (dec); [α]D
20  +271.2 (c 0.16, CHCl3); Chiral HPLC 
OD-H (97:3 hexane : IPA, flow rate 1.0 mL·min
-1
, 211 nm, 30 °C) syn: tR minor: 34.3 min, tR 
major: 42.2 min, ˃99% ee, anti: tR major: 51.3 min, tR minor: 59.2 min, ˃99% ee; νmax (film, 
cm
-1
) 1772 and 1701 (C=O isoxindole), 1701 (C=O); 
1
H NMR (500 MHz, CDCl3) δH: 1.50–
1.60 (1H, m, C(3)CH
A
H
B
), 2.06–2.16 (1H, m, C(3)CHAHB), 2.95 (1H, q, J 7.0, C(3)H), 3.76–
3.85 (1H, m, C(3)CH2CH
A
H
B
), 3.85–3.92 (1H, m, C(3)CH2CH
A
H
B
), 4.00 (1H, t, J 7.0, 
C(4)H), 6.42 (1H, d, J 6.9, C(5)H), 7.12–7.16 (2H, m, ArH), 7.29–7.38 (3H, m, ArH), 7.70–
7.75 (2H, m, C(3)(CH2)2Ar(2,5)H), 7.83–7.88 (2H, m, C(3)(CH2)2Ar(3,4)H); 
13
C{
1
H} (101 
MHz, CDCl3) δC: 26.3 (CH2), 35.6(CH2), 40.7 (C(3)), 40.9 (C(4)), 90.0 (CCl3), 108.1 (C(5)), 
123.4 (ArCH × 2), 128.0 (ArCH × 2), 128.5 (ArCH), 129.4 (ArCH × 2), 132.0 (NPhthArC), 
134.1 (ArCH), 135.7 (NPhthArC), 149.3 (C(3)ArC(1)), 167.5 (C(2)), 168.4 (C=O × 2); m/z 
(NSI
+
) 951 ([2M(
35
Cl2,
37
Cl)+Na]
+
, 100%), 949 ([2M(
35
Cl3)+Na]
+
, 85%), 486 
([M(
35
Cl3)+Na]
+
, 85%); HRMS (NSI
+
) C22H16O4N1
35
Cl3Na [M+Na]
+
 found 486.0041, 
requires 486.0037 (+0.8 ppm). 
(3S,4S)-3-(4-Methoxybenzyl)-4-phenyl-6-(trichloromethyl)-3,4-dihydro-2H-pyran-2-one 
(15). Following the general procedure, 1-(4-methoxyphenyl)-3-oxopropan-2-yl 4-
nitrobenzoate (99 mg, 0.30 mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 1 (50 mg, 0.20 
mmol), NHC precatalyst 11 (7.4 mg, 0.020 mmol) and Et3N (42 µL, 0.30 mmol) in 
anhydrous CH2Cl2 (2.7 mL) at rt for 26 h gave a brown oil (˃95:5 dr) that was purified by 
column chromatography (95:5 petrol : EtOAc) to give the title compound (53 mg, 65%) as a 
yellow oil. [α]D
20 +300.0 (c 0.81, CHCl3); Chiral HPLC AD-H (99:1 hexane : IPA, flow rate 
1.0 mL·min
-1
, 220 nm, 30 °C) tR minor: 18.5 min, tR major: 20.7 min, ˃99% ee; νmax (film, 
cm
-1
) 1780 (C=O), 1612 (C=C), 1514 (Ar C=C), 1456, 1250 (Ph–O–CH3); 
1
H NMR (500 
MHz, CDCl3) δH: 2.35 (1H, dd, J 14.4, 9.1, C(3)CH
A
H
B
), 3.15–3.27 (2H, m, C(3)CHAHB and 
C(3)H), 3.68 (1H, t, J 6.8, C(4)H), 3.81 (3H, s, CH3O), 6.36 (1H, d, J 6.7, C(5)H), 6.85 (2H, 
dd, J 9.1, 2.5, C(3)CH2ArC(3,5)H), 6.99–7.08 (4H, m, C(3)CH2ArC(2,6)H and 
C(4)ArC(3,5)H), 7.31–7.39 (3H, m, C(4)ArC(2,4,6)H); 13C{1H} (126 MHz, CDCl3) δC: 31.1 
(C(3)CH2), 39.9 (C(4)), 45.0 (C(3)), 55.3 (OCH3), 90.1 (CCl3), 108.6 (C(5)), 114.0 
(C(3)CH2ArC(3,5)), 128.3 (ArCH), 128.4 (ArCH), 129.2 (ArCH), 129.7(ArCH), 129.7 
(ArCH), 129.9 (ArCH), 136.0 (C(4)ArC(1)), 149.1 (C(6)), 158.4 (C(3)CH2ArC(4)), 167.9 
(C(2)); m/z (NSI
+
) 462 ([M(
35
Cl2, 
37
Cl)+MeOH+NH4]
+
, 51%), 460 ([M(
35
Cl3)+MeOH+NH4]
+
, 
52%), 445 ([M(
35
Cl2, 
37
Cl)+MeOH+H]
+
, 65%), 443 ([M(
35
Cl3)+MeOH+H]
+
, 67%), 432 
([M(
35
Cl,
37
Cl2)+NH4]
+
, 30%), 430 ([M(
35
Cl2,
37
Cl)+NH4]
+
, 97%), 428 ([M(
35
Cl3)+NH4]
+
, 
100%), 411 ([M(
35
Cl2,
37
Cl)+H]
+
, 43%); HRMS (NSI
+
) C20H18O3Cl3 [M+H]
+
 found 411.0321, 
requires 411.0316 (+1.2 ppm). 
(3S,4S)-(-3-(Benzo[d][1,3]dioxol-5-ylmethyl)-4-phenyl-6-(trichloromethyl)-3,4-dihydro-
2H-pyran-2-one (16). Following the general procedure, 1-(benzo[d][1,3]dioxol-5-yl)-3-
oxopropan-2-yl 4-nitrobenzoate (103 mg, 0.30 mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-
2-one 1 (50 mg, 0.20 mmol), NHC precatalyst 11 (3.7 mg, 0.010 mmol) and Et3N (42 µL, 
0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 26 h gave a brown oil (85:15 dr) that was 
purified by column chromatography (95:5 petrol : EtOAc) to give the title compound (38 mg, 
45%) as a white solid. mp 145–147 °C; [α]D
20 +230.4 (c 0.51, CH2Cl2); ee could not be 
determined by either chiral HPLC or GC; νmax (film, cm
-1
) 1780 (C=O), 1504, 1489 and 1445 
(Ar C=C), 1246 (C-O); 
1
H NMR (500 MHz, CDCl3) δH: 2.33 (1H, dd, J 14.5, 9.1, 
C(3)CH
A
H
B
), 3.15 (1H, dd, J 14.5, 5.3, C(3)CH
A
H
B
), 3.18–3.22 (1H, m, C(3)H), 3.71 (1H, t, 
J 6.7, C(4)H), 5.96 (2H, dd, J 4.6, 1.4, OCH2O), 6.37 (1H, d, J 6.8, C(5)H), 6.53 (1H, dd, J 
7.9, 1.5, C(3)CH2ArC(6)H), 6.61 (1H, app d, J 1.6, C(3)CH2ArC(4)H), 6.75 (1H, d, J 7.9, 
C(3)CH2ArC(7)H), 7.05–7.07 (2H, m, C(4)ArC(3,5)H), 7.32–7.39 (3H, m, 
C(4)ArC(2,4,6)H); 
13
C{
1
H} (126 MHz, CDCl3) δC: 31.8 (C(4)CH2), 39.9 (C(4)), 45.1 (C(3)), 
90.1 (CCl3), 101.0 (OCH2O), 108.4 (C(3)CH2ArC(7)), 108.6 (C(5)), 109.1 (C(3)CH2ArC(4)), 
122.0 (C(3)CH2ArC(6)), 128.3 (C(4)ArCH), 128.4 (C(4)ArCH), 129.3 (C(4)ArCH), 131.4 
(C(3)CH2ArC(5)), 135.9 (C(4)ArC(1)), 146.4 (C(3)CH2ArC(3a)), 147.8 (C(3)CH2ArC(7a)), 
149.0 (C(6)), 167.8 (C(2)); m/z (NSI
+
) 481 ([M(
35
Cl2,
37
Cl)+MeOH+Na]
+
, 65%), 479 
([M(
35
Cl3)+MeOH+Na]
+
, 67%), 449 ([M(
35
Cl2, 
37
Cl)+Na]
+
, 50%), 447 ([M(
35
Cl3) +Na]
+
, 
52%), 444 ([M(
35
Cl2,
37
Cl)+NH4]
+
, 31%), 442 ([M(
35
Cl3)+NH4]
+
, 34%), 429 ([M(
35
Cl, 
37
Cl2)+H]
+
, 30%), 427 ([M(
35
Cl2, 
37
Cl)+H]
+
, 94%), 425 [M(
35
Cl3)+H]
+
, 100%); HRMS (NSI
+
) 
C20H16O4
35
Cl3 [M+H]
+
 found 425.0107, requires 425.0109 (–0.4 ppm). 
(3S,4S)-3-Benzyl-4-(4-methoxyphenyl)-6-(trichloromethyl)-3,4-dihydro-2H-pyran-2-one 
(17). Following the general procedure, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (270 mg, 
0.90 mmol), (E)-1,1,1-trichloro-4-(4-methoxyphenyl)but-3-en-2-one (168 mg, 0.60 mmol), 
NHC precatalyst 11 (11.1 mg, 0.030 mmol) and Et3N (126 µL, 0.90 mmol) in anhydrous 
CH2Cl2 (8.2 mL) at rt for 3 h gave a brown oil (˃95:5 dr) that was purified by column 
chromatography (90:10 petrol : EtOAc) to give the title compound (229 mg, 93%) as a white 
solide. mp 109–111 °C; [α]D
20 +369.6 (c 0.575, CH2Cl2); Chiral HPLC AD-H (98:2 hexane : 
IPA, flow rate 1.0 mL·min
-1
, 220 nm, 30 °C) tR minor: 11.2 min, tR major: 12.6 min, 99% ee; 
νmax (film, cm
-1
) 1778 (C=O), 1609 (C=C), 1512 (Ar C=C), 1252 (Ph-O-CH3); 
1
H NMR (500 
MHz, CDCl3) δH: 2.41 (1H, dd, J 15.8, 10.6, C(3)CH
A
H
B
), 3.23–3.30 (2H, m, C(3)CHAHB 
and C(3)H), 3.62 (1H, t, J 6.7, C(4)H), 3.82 (3H, s, CH3), 6.35 (1H, d, J 6.8, C(5)H), 6.87–
6.97 (4H, m, C(4)ArH), 7.10–7.14 (2H, m, ArH), 7.24–7.28 (1H, m, ArH), 7.30–7.35 (2H, m, 
ArH); 
13
C{
1
H} (126 MHz, CDCl3) δC: 32.0 (CH2), 39.1 (C(4)), 45.0 (C(3)), 55.3 (CH3O), 
90.1 (CCl3), 108.9 (C(5)), 114.6 (C(4)ArCH), 126.8 (C(3)CH2ArCH), 127.6 (C(4)ArC(1)), 
128.7 (C(3)CH2ArCH), 129.0 (C(3)CH2ArCH), 129.4 (C(4)ArCH), 137.9 (C(3)CH2ArC), 
148.8 (C(6)), 159.6 (C(4)ArC(4)), 168.0 (C(2)); m/z (APCI
+
) 411 ([M(
35
Cl3)+H]
+
, 100%), 
303 ([M(
35
Cl3)–4-OMeC6H4]
+
, 70%); HRMS (APCI
+
) C20H17
35
Cl3O3 [M+H]
+
 found 
411.0313, requires 411.0316 (–0.7 ppm). 
(3S,4S)-3-Benzyl-4-(4-bromophenyl)-6-(trichloromethyl)-3,4-dihydro-2H-pyran-2-one (18). 
Following the general procedure, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (90 mg, 0.30 
mmol), (E)-4-(4-bromophenyl)-1,1,1-trichlorobut-3-en-2-one (70 mg, 0.20 mmol), NHC 
precatalyst 11 (3.7 mg, 0.010 mmol) and Et3N (42 µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 
mL) at rt for 1.5 h gave a brown oil (˃95:5 dr) that was purified by column chromatography 
(90:10 petrol : EtOAc) to give the title compound (60 mg, 95% pure, 55%) as a yellow oil. 
[α]D
20 +71.4 (c 0.29, CH2Cl2); Chiral HPLC OD-H (97:3 hexane : IPA, flow rate 1.0 mL·min
-
1
, 220 nm, 30 °C) tR major: 10.3 min, tR minor: 11.7 min, ˃99% ee; νmax (film, cm
-1
) 1780 
(C=O), 1661 (C=C); 
1
H NMR (400 MHz, CDCl3) δH: 2.33–2.42 (1H, m, C(3)CH
A
H
B
), 3.24–
3.35 (2H, m, C(3)CH
A
H
B
 and C(3)H), 3.64 (1H, t, J 6.7, C(4)H), 6.33 (1H, d, J 6.8, C(5)H), 
6.86–6.93 (2H, m, C(4)ArC(2,6)H), 7.07–7.12 (2H, m, C(3)ArH), 7.27–7.36 (3H, m, 
C(3)ArH), 7.46–7.52 (2H, m, C(4)ArC(3,5)H); 13C{1H}(101 MHz, CDCl3) δC: 32.0 (CH2), 
39.2 (C(4)), 44.4 (C(3)), 90.2 (CCl3), 108.0 (C(5)), 123.0 (C(4)ArC(1)), 127.0 
(C(3)CH2ArCH), 128.8 (C(3)CH2ArCH), 128.9 (C(3)CH2ArCH), 129.9 (C(4)ArC(2,6)), 
132.4 (C(4)ArC(3,5)), 135.1 (C(4)ArC(4)), 137.8 (C(3)CH2ArC), 146.6 (C(6)), 167.7 (C(2)); 
m/z (APCI
+
) 463 ([M(
35
Cl,
37
Cl2,
79
Br)+H]
+
, 60%), 461 ([M(
35
Cl2,
37
Cl,
79
Br)+H]
+
, 100%), 458 
([M(
35
Cl3,
79
Br)+H]
+
, 50%); HRMS (APCI
+
) C19H15O2
79
Br
35
Cl3 [M+H]
+
 found 458.9312, 
requires 458.9316 (–0.8 ppm). 
(3S,4S)-3-Methyl-4-pentyl-6-(trichloromethyl)-3,4-dihydro-2H-pyran-2-one (19). 
Following the general procedure, 1-oxopropan-2-yl 4-nitrobenzoate 10 (67 mg, 0.30 mmol), 
(E)-1,1,1-trichloronon-3-en-2-one (49 mg, 0.20 mmol), NHC precatalyst 11 (7.4 mg, 0.020 
mmol) and Et3N (42 µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 22 h gave a 
crude brown solid (>95:5 dr) that was purified by flash silica column chromatography (95:5 
hexane: EtOAc) to give the title compound (15 mg, >95% pure, 26%) as a yellow oil. [α]D
20 
+8.9 (c 0.44, CHCl3); Chiral GC analysis Restek Rt-bDEXcst (length: 30 m, thickness: 0.250 
mm, film thickness 0.25 μm) carrier gas: He, linear velocity: 20.0 cm·s-1, temperature: 160 
°C tR minor: 105.3 min, tR major: 106.9 min, ˃99% ee; νmax (film, cm
-1
) 1782 (C=O), 1668 
(C=C), 1458 (Ar C=C); 
1
H
 
NMR (400 MHz, CDCl3) δH: 0.88 (3H, t, J 6.9, CH3), 1.26 (3H, d, 
J 7.0, C(3)CH3), 1.27–1.40 (7H, m, C(4)CH
A
H
B
 and CH3(CH2)3), 1.50–1.55 (1H, m, 
C(4)CH
A
H
B
), 2.53–2.64 (1H, m, C(4)H), 2.81 (1H, p, J 7.0, C(3)H), 6.18 (1H, d, J 5.8, 
C(5)H); 
13
C{
1
H} NMR (101 MHz, CDCl3) δC: 11.3 (C(3)CH3), 14.0 (CH3), 22.4 (CH3CH2), 
26.0 (CH3(CH2)2CH2), 28.8 (C(4)CH2), 31.8 (CH3CH2CH2), 35.3 (C(4)), 36.9 (C(3)), 90.1 
(CCl3), 109.2 (C(5)), 148.4 (C(6)), 169.9 (C(2)); m/z (APCI
+
) 319 ([M(
35
Cl2,
37
Cl)+H3O]
+
, 
62%), 317 ([M(
35
Cl3)+H3O]
+
, 65%), 303 ([M(
35
Cl,
37
Cl2)+H]
+
, 30%), 301 
([M(
35
Cl2,
37
Cl)+H]
+
, 95%), 299 ([M(
35
Cl3)+H]
+
, 100%); HRMS (APCI
+
) C12H17
35
Cl3O2
+
 
[M+H]
+
 found 299.0366, requires 299.0367 (–0.3 ppm). 
Epimerization of 14: In an NMR tube, 2-(2-((3S,4S)-2-oxo-4-phenyl-6-(trichloromethyl)-
3,4-dihydro-2H-pyran-3-yl)ethyl)isoindo-line-1,3-dione 14 (13.2 mg, 0.028 mmol, 1.0 eq) 
was dissolved in CD2Cl2 before Et3N (5.9 µL, 0.42 mmol, 1.5 eq) was added. The ratio 
between the two diastereoisomers were monitored by 
1
H NMR comparing the ratio between 
syn-C(5)H (δH 6.21 (1H, d, J 3.7)) and anti-C(5)H (δH 6.45 (1H, d, J 6.9)). Chiral HPLC OD-
H (97:3 hexane : IPA, flow rate 1.0 mL·min
-1
, 211 nm, 30 °C) syn: tR minor: 34.3 min, tR 
major: 42.2 min, ˃99% ee, anti: tR major: 51.3 min, tR minor: 59.2 min, ˃99% ee. 
General Procedure for the NHC-catalyzed redox [4+2]-hetero-Diels-Alder reaction 
followed by ring-opening and aminolysis: The appropriate α-aroyloxyaldehyde (0.30 
mmol, 1.5 eq), the appropriate trichloromethyl ketone (0.20 mmol, 1.0 eq) and NHC 
precatalyst 11 (0.010 mmol, 5 mol% or 0.020 mmol, 10 mol%) were dissolved in anhydrous 
CH2Cl2 (2.7 mL). Et3N (0.30 mmol, 1.5 eq) was added and the reaction mixture was stirred at 
rt until complete by TLC analysis. The mixture was diluted in EtOAc (10 mL) and washed 
with water (10 mL × 2), sodium bisulfite aq. 40% (10 mL × 2), and brine (10 mL × 2). The 
organic layer was dried over MgSO4, filtered and concentrated. The crude syn-
dihydropyranone was dissolved in anhydrous CH2Cl2 (6.6 mL) and benzylamine (60 mmol, 
300 eq, 6.6 mL) was added. The reaction mixture was stirred at rt for 16 h before being 
diluted in EtOAc (20 ml) and washed with 1 M HCl (20 mL × 3), sat. aq. NaHCO3 (20 mL × 
3) and brine (20 mL × 3). The organic layer was dried over MgSO4, filtered and concentrated 
to give the crude product that was triturated in Et2O then dispersed in CHCl3 and 
concentrated to give the desired diamide. 
(2S,3S)-N
1
,N
5
-Dibenzyl-2-methyl-3-phenylpentanediamide (21). Following the general 
procedure, 1-oxopropan-2-yl 4-nitrobenzoate 10 (67 mg, 0.30 mmol), (E)-1,1,1-trichloro-4-
phenylbut-3-en-2-one 1 (50 mg, 0.20 mmol), NHC precatalyst 11 (3.7 mg, 0.010 mmol) and 
Et3N (42 µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 3.5 h gave a crude orange 
solid (˃95:5 dr). The crude was stirred in anhydrous CH2Cl2 (6.6 mL) with benzylamine (6.6 
mL, 60 mmol) at rt for 16 h to give a crude beige solid (dr˃95:5) that was triturated in Et2O 
to give the title compound (70 mg, 85%) as a white solid. mp 172–174 °C; [α]D
20 –8.7 (c 0.53, 
CHCl3); Chiral HPLC AD-H (90:10 hexane : IPA, flow rate 1.0 mL·min
-1
, 211 nm, 30 °C) tR 
minor: 15.3 min, tR major: 19.1 min, ˃99% ee; νmax (film, cm
-1
) 3283 (N–H), 3258 (N–H), 
1636 (C=O), 1558 (N–C=O), 1541 (N–C=O), 1495, 1454, 1435; 1H NMR (400 MHz, CDCl3) 
δH: 1.20 (3H, d, J 6.9, C(2)CH3), 2.48 (1H, dd, J 13.8, 8.6, C(4)H
A
H
B
), 2.67 (1H, p, J 7.0, 
C(2)H), 2.91 (1H, dd, J 13.8, 6.9, C(4)H
A
H
B
), 3.36 (1H, q, J 7.7, C(3)H), 4.14 (1H, dd, J 
14.7, 5.2, N
1
CH
A
H
B
), 4.24 (1H, dd, J 14.9, 5.4, N
5
CH
A
H
B
), 4.31 (1H, dd, J 14.7, 6.1, 
N
1
CH
A
H
B
), 4.38 (1H, dd, J 14.8, 6.1, N
5
CH
A
H
B
), 5.58 (1H, br t, J 5.0, N
1
H), 6.10 (1H, br t, J 
5.0, N
5
H), 6.87–6.96 (3H, dd, J 6.6, 2.8, ArH), 6.97–7.02 (3H, m, ArH), 7.11–7.18 (3H, m, 
ArH), 7.19–7.26 (8H, m); 13C{1H} NMR (101 MHz, CDCl3) δC: 16.0 (C(2)CH3), 40.5 (C(4)), 
43.3 (NCH2), 43.4 (NCH2), 45.7 (C(2)), 46.4 (C(3)), 127.1 (ArCH), 127.27 (ArCH), 127.33 
(ArCH), 127.5 (ArCH), 127.7 (ArCH), 128.3 (ArCH), 128.6 (ArCH), 137.9 (NCH2ArC(1)), 
138.1 (NCH2ArC(1)), 141.3 (C(3)ArC), 171.4 (C(5)), 174.0 (C(1)); m/z (NSI
+
) 823 
([2M+Na]
+
, 44%), 423 ([M+Na]
+
, 42%), 401 ([M+H]
+
, 100%); HRMS (NSI
+
) C26H29O2N2 
[M+H]
+ 
found 401.2221, requires 401.2224 (–0.6 ppm). 
  
(2S,3S)-Methyl 6,6,6-trichloro-2-methyl-5-oxo-3-phenylhexanoate (22) and (2S,3S)-
Dimethyl 2-methyl-3-phenylpentanedioate (23). 1-Oxopropan-2-yl 4-nitrobenzoate 10 (0.30 
mmol, 67 mg, 1.5 eq), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 1 (0.20 mmol, 50 mg, 1.0 
eq) and NHC precatalyst 11 (0.010 mmol, 3.7 mg, 5 mol%) were dissolved in anhydrous 
CH2Cl2 (2.7 mL). Et3N (0.30 mmol, 42 µL, 1.5 eq) was added and the reaction mixture was 
stirred at rt for 3.5 h. The mixture was diluted in EtOAc (10 mL) and washed with water (10 
mL × 2), sodium bisulfte aq. 40% (10 mL × 2) and brine (10 mL × 2). The organic layer was 
dried with MgSO4, filtered and concentrated to give a crude orange solid (˃95:5 dr). The 
crude was dissolved in anhydrous CH2Cl2 (2.4 mL) with MeOH (60 mmol, 2.4 mL, 300 eq) 
and DMAP (0.04 mmol, 5.0 mg, 20 mol%). The reaction mixture was stirred at rt for 16 h 
before being concentrated to give a crude orange oil (˃95:5 dr) that was purified by flash 
silica column chromatography (98:2 to 90:10 hexane: EtOAc) to give: 
22 (35 mg, 50%) as a colourless oil. [α]D
20 –17.3 (c 1.60, CHCl3); Chiral HPLC AD-H (99:1 
hexane : IPA, flow rate 1.0 mL·min
-1
, 211 nm, 30 °C) tR minor: 8.0 min, tR major: 9.7 min, 
˃99% ee; νmax (film, cm
-1
) 1734 (C=O), 1456, 1198, 1167; 
1
H NMR (400 MHz, CDCl3) δH: 
1.23 (3H, d, J 7.0, C(2)CH3), 2.86 (1H, p, J 7.0, C(2)H), 3.49 (2H, dd, J 6.9, 2.7, C(4)H2), 
3.52 (3H, s, C(1)OCH3), 3.54–3.62 (1H, m, C(3)H), 7.17–7.24 (3H, m, ArH), 7.24–7.31 (2H, 
m, ArH); 
13
C{
1
H} NMR (101 MHz, CDCl3) δC: 14.8 (C(2)CH3), 36.8 (C(4)), 44.0 (C(3)), 
44.7 (C(2)), 51.6 (C(1)OCH3), 96.2 (C(6)), 127.3 (ArCH), 128.1 (ArCH × 2), 128.4 (ArCH × 
2), 140.3 (C(3)ArC(1)), 174.9 (C(1)), 188.7 (C(5)); m/z (APCI
+
) 356 ([M(
35
Cl2,
37
Cl)+NH4]
+
, 
34%), 354 ([M(
35
Cl3)+ NH4]
+
, 34%), 341 ([M(
35
Cl,
37
Cl2)+H]
+
, 34%), 339 
([M(
35
Cl2,
37
Cl)+H]
+
, 99%), 337 ([M(
35
Cl3)+H]
+
, 100%); HRMS (APCI
+
) C14H15O3
35
Cl3 
[M+H]
+
 found 337.0160, requires 337.0164 (+1.3 ppm). 
23 (10 mg, 20%, 85% pure) as a yellow oil.
35,36
 [α]D
20 +0.46 (c 0.44, CHCl3); Chiral HPLC 
AD-H (99:1 hexane : IPA, flow rate 1.0 mL·min
-1
, 211 nm, 30 °C) major diastereoisomer: tR 
minor: 13.8 min, tR major: 15.1 min, 98% ee, minor diastereoisomer: tR minor: 12.3 min, tR 
major: 13.0 min, ˃99% ee; νmax (film, cm
-1
) 1734 (C=O), 1456, 1453, 1258, 1198, 1161; 
1
H 
NMR (400 MHz, CDCl3) δH: 1.18 (3H, d, J 7.0, C(2)CH3), 2.69 (1H, dd, J 15.7, 9.7, 
C(4)H
A
H
B
), 2.74–2.87 (2H, m, C(4)HAHB and C(2)H), 3.41–3.48 (1H, m, C(3)H), 3.50 (3H, 
s, C(1)OCH3), 3.54 (3H, s, C(5)OCH3), 7.14–7.23 (3H, m, ArH), 7.24–7.30 (2H, m, ArH); 
13
C{
1
H} NMR (101 MHz, CDCl3) δC: 14.4 (C(2)CH3), 37.0 (C(4)), 44.5 (C(3)), 45.1 (C(2)), 
51.5 (C(1)OCH3), 51.6 (C(5)OCH3), 126.9 (C(3)ArCH), 127.8 (C(3)ArCH × 2), 128.3 
(C(3)ArCH × 2), 141.3 (C(3)ArC(1)), 172.4 C(5), 175.2 C(2); m/z (NSI
+
) 251 ([M+H]
+
, 
100%); HRMS (NSI
+
) C14H19O4 [M+H]
+ 
found 251.1279, requires 251.1278 (+0.5 ppm).
 
(2S,3S)-Benzyl 5-(benzylamino)-2-methyl-5-oxo-3-phenylpentanoate (24). 1-Oxopropan-2-
yl 4-nitrobenzoate 10 (0.30 mmol, 67 mg, 1.5 eq), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 
1 (0.20 mmol, 50 mg, 1.0 eq) and NHC precatalyst 11 (0.010 mmol, 3.7 mg, 5 mol%) were 
dissolved in anhydrous CH2Cl2 (2.7 mL). Et3N (0.30 mmol, 42 µL, 1.5 eq) was added and the 
reaction mixture was stirred at rt for 3.5 h. The mixture was diluted in EtOAc (10 mL) and 
washed with water (10 mL × 2), sodium bisulfite aq. 40% (10 mL × 2), and brine (10 mL × 
2). The organic layer was dried over MgSO4, filtered and concentrated to give a crude orange 
solid (77 mg, ˃95:5 dr). The crude was dissolved in anhydrous CH2Cl2 (6.6 mL) with BnOH 
(60 mmol, 6.6 mL, 300 eq) and DMAP (0.04 mmol, 5 mg, 20 mol%). The reaction mixture 
was stirred at rt for 16 h before being concentrated. Excess BnOH was removed by Kugelrohr 
distillation to give a crude orange oil (105 mg, ˃95:5 dr). The oil was stirred in anhydrous 
CH2Cl2 (2.6 mL) with benzylamine (2.6 mL, 0.24 mmol, 1.2 eq) at rt for 16 h. The reaction 
mixture was diluted in EtOAc (20 ml) and wash with 1 M HCl (20 mL × 3), sat. aq. NaHCO3 
(20 mL × 3) and brine (20 mL × 3). The organic layer was dried over MgSO4, filtered and 
concentrated to give a crude orange oil (105 mg, ˃95:5 dr) that was purified by Biotage® 
Isolera™ 4 [SNAP Ultra 10 g, 36 mL min−1, hexane : EtOAc (80:20 1 CV, 80:20 to 50:50 15 
CV, 50:50 5 CV)] to give the title compound (26 mg, 32%) as a yellow solid. mp 98–100 °C; 
[α]D
20 +6.92 (c 0.52, CHCl3); Chiral HPLC AD-H (90:10 hexane : IPA, flow rate 1.0 mL·min
-
1
, 211 nm, 30 °C) tR minor: 19.7 min, tR major: 26.2 min, ˃99% ee; νmax (film, cm
-1
) 3319, 
3269, 1720 (C(1)=O), 1643 (C(5)=O), 1549 (N–C=O), 1495, 1454, 1256; 1H NMR (400 
MHz, CDCl3) δH: 1.24 (3H, d, J 7.0, C(2)CH3), 2.44 (1H, dd, J 14.0, 9.8, C(4)H
A
H
B
), 2.79 
(1H, dd, J 14.0, 5.6, C(4)H
A
H
B
), 2.82–2.92 (1H, m, C(2)H), 3.40–3.50 (1H, m, C(3)H), 4.18 
(1H, dd, J 14.8, 5.3, NCH
A
H
B
), 4.34 (1H, dd, J 14.8, 6.2, NCH
A
H
B
), 4.88 (1H, d, J 12.3, 
OCH
A
H
B
), 4.93 (1H, d, J 12.3, OCH
A
H
B
), 5.51 (1H, t, J 5.1, NH), 6.87–6.94 (2H, m, ArH), 
7.09–7.17 (4H, m, ArH), 7.18–7.25 (6H, m, ArH), 7.26–7.32 (3H, m, ArH); 13C{1H} NMR 
(101 MHz, CDCl3) δC: 15.3 (C(2)CH3), 40.5 (C(4)), 43.4 (NCH2), 44.8 (C(2)), 45.8 (C(3)), 
66.2 (OCH2), 127.1 (ArCH), 127.3 (ArCH), 127.5 (ArCH), 128.1 (ArCH), 128.2 (ArCH), 
128.48 (ArCH), 128.54 (ArCH), 135.7 (OCH2ArC(1)), 137.9 (NCH2ArC(1)), 141.1 
(C(3)ArC(1)) 170.9 (C(5)), 174.6 (C(1)); m/z (NSI
+
) 424 ([M+Na]
+
, 33%), 402 ([M+H]
+
, 
100%); HRMS (NSI
+
) C26H28O3N1 [M+H]
+
 found 402.2062, requires 402.2064 (–0.4 ppm). 
(2S,3S)-N
1
,N
5
-Dibenzyl-2-butyl-3-phenylpentanediamide (25). Following the general 
procedure, 1-oxohexan-2-yl 4-nitrobenzoate (80 mg, 0.30 mmol), (E)-1,1,1-trichloro-4-
phenylbut-3-en-2-one 1 (50 mg, 0.20 mmol), NHC precatalyst 11 (7.4 mg, 0.020 mmol) and 
Et3N (42 µL, 0.30 mmol) in anhydrous THF (2.7 mL) at rt for 3 h gave a crude brown-green 
oil (˃95:5 dr). The crude was stirred in anhydrous CH2Cl2 (6.6 mL) with benzylamine (6.6 
mL, 60 mmol) at rt for 16 h to give a crude beige solid (˃95:5 dr) that was triturated in Et2O 
to give the title compound (78 mg, 89%) as a white solid. mp 205–207 °C; [α]D
20 –21.6 (c 
0.63, CHCl3); Chiral HPLC AD-H (90:10 hexane : IPA, flow rate 1.0 mL·min
-1
, 211 nm, 30 
°C) tR minor: 11.9 min, tR major: 17.7 min, ˃99% ee; νmax (film, cm
-1
) 3279 (N–H), 3252 (N–
H), 1636 (C=O), 1558 (N–C=O), 1495, 1454; 1H NMR (400 MHz, CDCl3) δH: 0.87 (3H, t, J 
6.9, CH3), 1.19–1.34 (4H, m, C(2)CH2(CH2)2), 1.52–1.60 (2H, m, C(2)CH2), 2.41–2.51 (2H, 
m, C(2)H and C(4)H
A
H
B
), 2.89 (1H, dd, J 13.8, 7.0, C(4)H
A
H
B
), 3.38 (1H, q, J 8.0, C(3)H), 
4.13 (1H, dd, J 14.7, 5.1, N
1
CH
A
H
B
), 4.26 (1H, dd, J 14.8, 5.4, N
5
CH
A
H
B
), 4.30 (1H, dd, J 
14.8, 6.2, N
1
CH
A
H
B
), 4.36 (1H, dd, J 14.8, 6.1, N
5
CH
A
H
B
), 5.48 (1H, t, J 5.3, N
1
H), 5.96 
(1H, t, J 5.1, N
5
H), 6.90–6.95 (2H, m, ArH), 6.98–7.03 (2H, m, ArH), 7.11–7.16 (2H, m, 
ArH), 7.19–7.26 (9H, m, ArH); 13C{1H} NMR (101 MHz, CDCl3) 14.0 (CH3), 22.7 (CH2), 
29.8 (CH2), 30.2 (C(2)CH2), 40.7 (C(4)), 43.3(NCH2), 43.5 (NCH2), 45.3 (C(3)), 52.2 (C(2)), 
127.0 (ArCH), 127.28 (ArCH), 127.32 (ArCH), 127.6 (ArCH × 2), 127.8 (ArCH × 2), 128.3 
(ArCH × 2), 128.50 (ArCH × 2), 128.53 (ArCH × 2), 128.6 (ArCH × 2), 138.0 (NCH2ArC), 
138.1 (NCH2ArC), 141.4 (C(3)ArC(1)), 171.4 (C(5)), 173.2 (C(1)); m/z (NSI
+
) 443 ([M+H]
+
, 
100%); HRMS (NSI
+
) C29H35O2N2 [M+H]
+
 found 443.2692, requires 443.2653 (–0.2 ppm). 
(2S,3S)-N
1
,N
5
-Dibenzyl-3-(4-fluorophenyl)-2-(4-methoxybenzyl)pentanediamide (26). 
Following the general procedure, 1-(4-methoxyphenyl)-3-oxopropan-2-yl 4-nitrobenzoate (99 
mg, 0.30 mmol), (E)-1,1,1-trichloro-4-(4-fluorophenyl)but-3-en-2-one (54 mg, 0.20 mmol), 
NHC precatalyst 11 (3.7 mg, 0.010 mmol) and Et3N (42 µL, 0.30 mmol) in anhydrous 
CH2Cl2 (2.7 mL) at rt for 6 h gave a crude brown oil (˃95:5 dr). The crude was stirred in 
anhydrous CH2Cl2 (6.6 mL) with benzylamine (6.6 mL, 60 mmol) at rt for 16 h to give a 
crude yellow solid (˃95:5 dr) that was triturated in Et2O to give the title compound (61 mg, 
60%) as a beige solid. mp 221–223 °C; [α]D
20 –23.9 (c 0.41, DMSO); Chiral HPLC AD-H 
(90:10 hexane : IPA, flow rate 1.5 mL·min
-1
, 211 nm, 40 °C) tR major: 16.9 min, tR minor: 
21.2 min, 98% ee; νmax (film, cm
-1
) 3343 (N–H), 3296 (N–H), 1639 (C=O), 1553 (N–C=O), 
1454, 1422, 1356; 
1
H NMR (700 MHz, CDCl3) δH: 2.52 (1H, dd, J 14.0, 8.5, C(4)H
A
H
B
), 
2.71–2.78 (1H, m, C(2)H), 2.77–2.83 (1H, m, C(2)CHAHB), 2.85–2.93 (2H, m, C(4)HAHB 
and C(2)CH
A
H
B
), 3.48 (1H, q, J 8.1, C(3)H), 3.79 (3H, s, OCH3), 4.00 (1H, dd, J 14.8, 5.6, 
N
1
CH
A
H
B
), 4.12 (1H, dd, J 14.9, 6.0, N
1
CH
A
H
B
), 4.28 (1H, dd, J 14.7, 5.5, N
5
CH
A
H
B
), 4.38 
(1H, dd, J 14.7, 6.0, N
5
CH
A
H
B
), 5.41 (1H, t, J 5.6, N
1
H), 5.78 (1H, t, J 5.1, N
5
H), 6.67–6.71 
(2H, m, ArH), 6.75–6.80 (2H, m, ArH), 6.89–6.95 (1H, m, ArH), 7.00–7.03 (1H, m, ArH), 
7.03–7.06 (1H, m, ArH), 7.12–7.18 (4H, m, ArH), 7.24–7.28 (6H, m, ArH); 13C{1H} NMR 
(126 MHz, CDCl3) δC:
 
35.7 (C(2)CH2), 40.7 (C(4)), 43.0 (N
1
CH2), 43.5 (N
5
CH2), 44.4 (C(3)), 
54.4 (C(2)), 55.2 (OCH3), 113.9 (C(2)CH2ArC(3,5)), 115.3 (d, JCF 21.2, C(3)ArC(3,5)), 127.2 
(NCH2ArC(4)), 127.5 (NCH2ArC(4) and N
1
CH2ArC(2,6)), 127.6 (N
5
CH2ArC(2,6)), 128.4 
(NCH2ArC(3,5)), 128.6 (NCH2ArC(3,5)), 129.87 (C(2)ArC(2,6)), 129.93 (d, JCF 7.8, 
C(3)ArC(2,6)), 131.1 (C(2)ArC(1)), 137.0 (d, JCF 3.0, C(3)ArC(1)), 137.8 (NCH2ArC), 137.9 
(NCH2ArC), 158.2 (C(2)CH2ArC(4)), 161.9 (d, J CF 245.3, C(3)ArC(4)), 170.9 (C(5)), 172.2 
(C(1));
 19
F NMR (376 MHz, CDCl3) δF: –115.57 (s, C(3)ArC(4)F); m/z (NSI
+
) 547 
([M+Na]
+
, 43%), 525 ([M+H]
+
, 100%); HRMS (NSI
+
) C33H34O3N2F [M+H]
+
 found 
525.2554, requires 525.2548 (+1.1 ppm). 
(2S,3S)-2-(Benzo[d][1,3]dioxol-5-ylmethyl)-N
1
,N
5
-dibenzyl-3-phenylpentanediamide (27). 
Following the general procedure, 1-(benzo[d][1,3]dioxol-5-yl)-3-oxopropan-2-yl 4-
nitrobenzoate (103 mg, 0.30 mmol), (E)-1,1,1-trichloro-4-phenylbut-3-en-2-one 1 (50 mg, 
0.20 mmol), NHC precatalyst 11 (3.7 mg, 0.010 mmol) and Et3N (42 µL, 0.30 mmol) in 
anhydrous CH2Cl2 (2.7 mL) at rt for 27 h gave a crude brown oil (85:15 dr). The crude was 
stirred in anhydrous CH2Cl2 (6.6 mL) with benzylamine (6.6 mL, 60 mmol) at rt for 16 h to 
give a crude brown solid (80:20 dr) that was triturated in Et2O to give the title compound (50 
mg, 48%) as an off-white solid. mp 198 °C (dec); [α]D
20 –39.4 (c 0.18, CHCl3); No ee could 
be determined by either chiral HPLC or chiral GC; νmax (film, cm
-1
) 3296 (N–H), 1643 
(C=O), 1553 (N–C=O), 1499, 1487, 1354; 1H NMR (400 MHz, CDCl3) δH: 2.57 (1H, dd, J 
14.0, 8.3, C(4)H
A
H
B
), 2.74–2.84 (2H, m, C(2)H and C(2)CHAHB), 2.84–2.96 (2H, m, 
C(2)H
A
H
B 
and C(4)H
A
H
B
), 3.43–3.52 (1H, m, C(3)H), 4.01–4.15 (2H, m, NCH2), 4.26–4.40 
(2H, m, NCH2), 5.43 (1H, t, J 5.2, NH), 5.83 (1H, t, J 5.3, NH), 5.88–5.94 (2H, m, OCH2O), 
6.56–6.62 (1H, m, C(2)CH2ArH), 6.62–6.70 (2H, m, C(2)CH2ArH), 6.70–6.75 (2H, m, ArH), 
6.99–7.05 (2H, m, ArH), 7.12–7.21 (5H, m, ArH), 7.22–7.25 (6H, m, ArH); 13C{1H} NMR 
(101 MHz, CDCl3) δC: 36.2 (C(2)CH2), 40.5 (C(4)), 43.0 (NCH2), 43.5 (NCH2), 45.2 (C(3)), 
54.4 (C(2)), 100.8 (OCH2O), 109.3 (C(2)CH2ArCH), 121.9 (C(2)CH2ArCH), 127.1 (ArCH × 
2), 127.4 (ArCH), 127.5 (ArCH × 2), 127.6 (ArCH × 2), 128.3 (ArCH × 2), 128.4 (ArCH × 
2), 128.6 (ArCH × 2), 128.6 (ArCH × 2), 133.1 (C(2)CH2ArC(1)), 137.8 (NCH2ArC(1)), 
138.0 (NCH2ArC(1)), 141.2 (C(3)ArC(1)), 146.0 (C(2)CH2ArC(2a or 6a)), 147.6 
(C(2)CH2ArC(6a or 2a)), 171.2 (C=O), 172.2 (C=O); m/z (NSI
+
) 543 ([M+Na]
+
, 31%), 521 
([M+H]
+
, 100%); HRMS (NSI
+
) C33H33O4N2 [M+H]
+
 found 521.2440, requires 521.2435 
(+1.0 ppm). 
(2S,3S)-N
1
,N
5
-Dibenzyl-3-(4-methoxyphenyl)-2-methylpentanediamide (28). Following the 
general procedure,1-oxopropan-2-yl 4-nitrobenzoate 10 (67 mg, 0.30 mmol), (E)-1,1,1-
trichloro-4-(4-methoxyphenyl)but-3-en-2-one (56 mg, 0.20 mmol), NHC precatalyst 11 (3.7 
mg, 0.010 mmol) and Et3N (42 µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 22 h 
gave a crude yellow solid (˃95:5 dr). The crude was stirred in anhydrous CH2Cl2 (6.6 mL) 
with benzylamine (6.6 mL, 60 mmol) at rt for 16 h to give a crude light yellow solid (˃95:5 
dr) that was triturated in Et2O to give the title compound (64 mg, 75%) as a white solid. mp 
176–178 °C; [α]D
20 –12.8 (c 0.56, CHCl3); Chiral HPLC AD-H (90:10 hexane : IPA, flow rate 
1.0 mL·min
-1
, 211 nm, 30 °C) tR minor: 18.1 min, tR major: 24.8 min, ˃99% ee; νmax (film, 
cm
-1
) 3273 (N–H), 1636 (C=O), 1558 (N–C=O), 1508, 1454, 1429, 1350, 1242; 1H NMR 
(400 MHz, CDCl3) δH: 1.22 (3H, d, J 6.9, C(2)CH3), 2.46 (1H, dd, J 13.8, 8.8, C(4)H
A
H
B
), 
2.64 (1H, p, J 6.9, C(2)H), 2.91 (1H, dd, J 13.8, 6.8, C(4)H
A
H
B
), 3.32 (1H, q, J 8.0, C(3)H), 
3.81 (3H, s, OCH3), 4.15 (1H, dd, J 14.7, 5.1, N
1
CH
A
H
B
), 4.25 (1H, dd, J 14.9, 5.3, 
N
5
CH
A
H
B
), 4.37 (1H, dd, J 14.8, 6.4, N
1
CH
A
H
B
), 4.42 (1H, dd, J 14.9, 6.3, N
5
CH
A
H
B
), 5.60 
(1H, t, J 5.5, N
1
H), 6.08 (1H, t, J 5.4, N
5
H), 6.74–6.82 (2H, m, C(3)ArC(3,5)H), 6.91–6.98 
(2H, m, ArH), 6.99–7.05 (2H, m, ArH), 7.05–7.11 (2H, m, C(3)ArC(2,6)H), 7.21–7.28 (6H, 
m, ArH); 
13
C{
1
H} NMR (101 MHz, CDCl3) δC: 16.0 (C(2)CH3), 40.8 (C(4)), 43.3 (N
1
CH2), 
43.4 (N
5
CH2), 45.6 (C(3)), 45.9 (C(2)), 55.2 (OCH3), 113.9 (C(3)ArC(3,5)), 127.26 (ArCH), 
127.33 (ArCH), 127.5 (ArCH), 127.7 (ArCH), 128.5 (ArCH), 129.2 (C(3)ArC(2,6)), 133.2 
(C(3)ArC(1)), 137.9 (NCH2ArC(1)), 138.1 (NCH2ArC(1)), 158.6 (C(3)ArC(4)), 171.5 (C(5)), 
174.1 (C(1)); m/z (NSI
+
) 883 ([2M+Na]
+
, 30%), 453 ([M+Na]
+
, 58%), 431 ([M+H]
+
, 100%); 
HRMS (NSI
+
) C27H31O3N2 [M+H]
+
 found 431.2328, requires 431.2329 (–0.3 ppm). 
(2S,3S)-N
1
,N
5
-Dibenzyl-2-methyl-3-(2-nitrophenyl)pentanediamide (29). Following the 
general procedure, 1-oxopropan-2-yl 4-nitrobenzoate 10 (67 mg, 0.30 mmol), (E)-1,1,1-
trichloro-4-(2-nitrophenyl)but-3-en-2-one (59 mg, 0.20 mmol), NHC precatalyst 11 (3.7 mg, 
0.010 mmol) and Et3N (42 µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 2 h gave a 
crude brown oil (˃95:5 dr). The crude was stirred in anhydrous CH2Cl2 (6.6 mL) with 
benzylamine (6.6 mL, 60 mmol) at rt for 16 h to give a crude light yellow solid (approx. 
90:10 dr) that was triturated in Et2O to give the title compound (60 mg, 68%) as a brown 
solid. mp 176 °C (dec.); [α]D
20 –2.3 (c 0.61, CHCl3); Chiral HPLC AD-H (95:5 hexane : IPA, 
flow rate 1.5 mL·min
-1
, 211 nm, 30 °C) tR major: 63.9 min, tR minor: 70.9 min, 99% ee; νmax 
(film, cm
-1
) 3292 (N–H), 1636 (C=O), 1558 (N–C=O), 1541 (N–C=O), 1522, 1456, 1354; 1H 
NMR (400 MHz, CDCl3) δH: 1.21 (3H, d, J 6.9, C(2)CH3), 2.60 (1H, dd, J 15.0, 9.3, 
C(4)H
A
H
B
), 2.80 (1H, p, J 7.1, C(2)H), 2.87 (1H, dd, J 15.0, 5.9, C(4)H
A
H
B
), 3.94–4.04 (1H, 
m, C(3)H), 4.21–4.34 (4H, m, NCH2 × 2), 6.06 (1H, t, J 4.9, NH), 6.31 (1H, t, J 5.4, NH), 
6.98–7.08 (4H, m, ArH), 7.18–7.25 (5H, m, ArH), 7.2–7.36 (1H, m, C(3)ArC(5)H), 7.36–
7.41 (1H, m, C(3)ArC(3)H), 7.42–7.49 (1H, m, C(3)ArC(4)H), 7.66 (2H, dd, J 8.1, 1.2, 
C(3)ArC(6)H); 
13
C{
1
H} NMR (101 MHz, CDCl3) δC: 15.1 (C(2)CH3), 38.6 (C(4)), 43.4 
(NCH2), 43.5 (NCH2), 45.2 (C(2)), 124.6 (C(3)ArC(6)), 127.3 (ArCH), 127.4 (ArCH), 127.6 
(ArCH), 127.6 (ArCH), 128.6 (ArCH), 132.6 (C(3)ArC(4)), 135.9 (C(3)ArC(1)), 137.9 
(NCH2ArC(1)), 138.1 (NCH2ArC(1)), 150.3 (C(3)ArC(2)), 170.4 (C(5)), 173.8 (C(1)), C(3) 
and C(3)ArC(3) not observed; m/z (NSI
+
) 468 ([M+Na]
+
, 33%), 446 ([M+H]
+
, 100%); 
HRMS (NSI
+
) found C26H28O4N3 found 446.2072, requires 446.2074 (–0.5 ppm). 
(2S,3S)-N
1
,N
5
-Dibenzyl-3-(4-fluorophenyl)-2-methylpentanediamide (30). Following the 
general procedure, 1-oxopropan-2-yl 4-nitrobenzoate 10 (67 mg, 0.30 mmol), (E)-1,1,1-
trichloro-4-(4-fluorophenyl)but-3-en-2-one (54 mg, 0.20 mmol), NHC precatalyst 11 (3.7 mg, 
0.010 mmol) and Et3N (42 µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 3 h gave a 
crude brown oil (˃95:5 dr). The crude was stirred in anhydrous CH2Cl2 (6.6 mL) with 
benzylamine (6.6 mL, 60 mmol) at rt for 16 h to give a crude beige solid (˃95:5 dr) that was 
triturated in Et2O to give the title compound (76 mg, 90%) as a white solid. mp 204–206 °C; 
[α]D
20 –2.5 (c 0.52, DMSO); Chiral HPLC AD-H (90:10 hexane : IPA, flow rate 1.0 mL·min-
1
, 211 nm, 30 °C) tR minor: 12.8 min, tR major: 19.1 min, ˃99% ee; νmax (film, cm
-1
) 3292 (N–
H), 1645 (C=O), 1541 (N–C=O), 1508, 1495, 1456, 1219; 1H NMR (400 MHz, CDCl3) δH: 
1.22 (3H, d, J 6.9, C(2)CH3), 2.45 (1H, dd, J 13.8, 8.7, C(4)H
A
H
B
), 2.65 (1H, p, J 7.0, 
C(2)H), 2.91 (1H, dd, J 13.8, 6.8, C(4)H
A
H
B
), 3.38 (1H, q, J 8.0, C(3)H), 4.16 (1H, dd, J 
14.7, 5.1, N
1
CH
A
H
B
), 4.26 (1H, dd, J 14.7, 5.3, N
5
CH
A
H
B
), 4.37 (1H, dd, J 15.1, 6.8, 
N
1
CH
A
H
B
), 4.42 (1H, dd, J 14.9, 6.4, N
5
CH
A
H
B
), 5.61 (1H, t, J 5.5, N
1
H), 6.01 (1H, t, J 5.5, 
N
5
H), 6.88–6.94 (1H, m, C(3)ArC(3)H), 6.94–6.98 (2H, m, ArH ×1 and C(3)ArC(5)H), 
7.00–7.06 (2H, m, ArH), 7.09–7.16 (2H, m, C(3)ArC(2,6)H), 7.23–7.28 (7H, m, ArH); 
13
C{
1
H} NMR (126 MHz, CDCl3) δC: 16.1 (C(2)CH3), 40.7 (C(4)), 43.3 (NCH2), 43.5 
(NCH2), 45.7 (C(2)), 45.7 (C(3)), 115.3 (d, JCF 21.1, C(2)ArC(3,5)), 127.4 (NCH2ArC(4)), 
127.5 (NCH2ArC(4)), 127.6 (ArCH × 2), 127.7 (ArCH × 2), 128.6 (ArCH × 4), 129.8 (d, JCF 
7.9, C(3)ArC(2,6)), 136.9 (d, JCF 3.1, C(3)ArC(1)), 137.8 (NCH2ArC(1)), 138.0 
(NCH2ArC(1)), 161.9 (d, J CF 245.3, C(3)ArC(4)), 171.2 (C(5)), 173.8 (C(1)); 
19
F (376 MHz, 
CDCl3) δF: –115.60 (s, C(3)ArC(4)F); m/z (NSI
+
) 441 ([M+Na]
+
, 51%), 419 ([M+H]
+
, 
100%); HRMS (NSI
+
) [M+H]
+
 C26H28O2N2F found 419.2129, requires 419.2129 (–0.1 ppm). 
(2S,3S)-N
1
,N
5
-Dibenzyl-3-(furan-2-yl)-2-methylpentanediamide (31). Following the general 
procedure, 1-oxopropan-2-yl 4-nitrobenzoate 10 (67 mg, 0.30 mmol), (E)-1,1,1-trichloro-4-
(furan-2-yl)but-3-en-2-one (48 mg, 0.20 mmol), NHC precatalyst 11 (3.7 mg, 0.010 mmol) 
and Et3N (42 µL, 0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 3 h gave a crude brown 
crystallised oil (95:5 dr). The crude was stirred in anhydrous CH2Cl2 (6.6 mL) with 
benzylamine (6.6 mL, 60 mmol) at rt for 16 h to give a crude beige solid (˃95:5 dr) that was 
triturated in Et2O to give the title compound (58 mg, 75%) as a beige solid. mp 192–194 °C; 
[α]D
20 –1.4 (c 0.50, CHCl3); Chiral HPLC AD-H (90:10 hexane : IPA, flow rate 1.0 mL·min
-1
, 
211 nm, 30 °C) tR major: 19.8 min, tR minor: 27.6 min, ˃99% ee; νmax (film, cm
-1
) 3279 (N–
H), 1645 (C=O), 1562 (N–C=O), 1541 (N–C=O), 1506, 1456; 1H NMR (400 MHz, CDCl3) 
δH: 1.19 (3H, d, J 7.0, C(2)CH3), 2.53 (1H, dd, J 13.9, 8.5, C(4)H
A
H
B
), 2.71 (1H, p, J 7.0, 
C(2)H), 2.80 (1H, dd, J 13.9, 6.7, C(4)H
A
H
B
), 3.49–3.58 (1H, m, C(3)H), 4.25–4.36 (3H, m, 
N
1
CH2 and N
5
CH
A
H
B
), 4.41 (1H, dd, J 14.8, 6.0, N
5
CH
A
H
B
), 5.76 (1H, t, J 5.2, N
1
H), 6.06–
6.10 (1H, m, C(3)ArC(5)H), 6.15 (1H, t, J 4.9, N
5
H), 6.25 (1H, dd, J 3.2, 1.9, C(3)ArC(4)H), 
7.10–7.18 (4H, m, ArH), 7.22 (1H, dd, J 1.8, 0.8, C(3)ArC(3)H), 7.23–7.32 (6H, m, ArH); 
13
C{
1
H} NMR (101 MHz, CDCl3) δC: 15.2 (C(2)CH3), 38.2 (C(4)), 39.8 (C(3)), 45.54 
(NCH2Ph), 45.55 (NCH2Ph), 43.9 (C(2)), 107.3 (C(3)ArC(5)), 110.3 (C(3)ArC(4)), 127.4 
(ArCH), 127.5 (ArCH), 127.7 (ArCH), 127.9 (ArCH), 128.60 (ArCH), 128.61 (ArCH), 138.0 
(NCH2ArC(1)), 138.2 (NCH2ArC(1)), 141.4 (C(3)ArC(3)), 154.6 (C(3)ArC(1)), 171.1 (C(5)), 
173.9 (C(1)); m/z (NSI
+
) 413 ([M+Na]
+
, 41%), 391 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C24H27O3N2 [M+H]
+
 found 391.2016, requires 391.2016 (+0.0 ppm). 
(2S,3S)-N
1
,N
5
,2-Tribenzyl-3-(furan-2-yl)pentanediamide (32). Following the general 
procedure, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate (90 mg, 0.30 mmol), (E)-1,1,1-
trichloro-4-(furan-2-yl)but-3-en-2-one (48 mg, 0.20 mmol), NHC precatalyst 11 (3.7 mg, 
0.010 mmol) and Et3N (42 µL, 0.30 mmol) in anhydrous THF (2.7 mL) at rt for 4 h gave a 
crude brown oil (˃95:5 dr). The crude was stirred in anhydrous CH2Cl2 (6.6 mL) with 
benzylamine (6.6 mL, 60 mmol) at rt for 16 h to give a crude orange solid (˃95:5 dr) that was 
triturated in Et2O to give the title compound (36 mg, 39%) as a off-white solid. mp 192–194 
°C; [α]D
20 –17.3 (c 0.48, CHCl3); Chiral HPLC AD-H (80:20 hexane : IPA, flow rate 1.5 
mL·min
-1
, 211 nm, 40 °C) tR major: 5.6 min, tR minor: 13.0 min, ˃99% ee; νmax (film, cm
-1
) 
3275 (N–H), 1638 (C=O), 1560 (N–C=O), 1533, 1495, 1452; 1H NMR (400 MHz, CDCl3) 
δH: 2.61 (1H, dd, J 14.0, 8.3, C(4)H
A
H
B
), 2.83–2.99 (4H, m, C(4)HAHB, C(2)H, C(2)CH2), 
3.59–3.68 (1H, m, C(3)H), 4.14 (1H, dd, J 14.8, 5.6, N1CHAHB), 4.21 (1H, dd, J 14.8, 5.9, 
N
1
CH
A
H
B
), 4.31–4.42 (2H, m, N5CH2), 5.62 (1H, t, J 5.5, N
1
H), 5.98 (1H, t, J 5.5, N
5
H), 
6.12–6.17 (1H, m, C(3)ArC(5)H), 6.29 (1H, dd, J 3.2, 1.9, C(3)ArC(4)H), 6.84–6.90 (2H, m, 
ArH), 7.10–7.17 (4H, m, ArH), 7.17–7.21 (4H, m, ArH), 7.21–7.25 (3H, m, ArH), 7.26–7.33 
(3H, m, ArH); 
13
C{
1
H} NMR (101 MHz, CDCl3) δC: 35.8 (C(2)CH2), 38.2 (C(4)), 38.6 
(C(3)), 43.3 (N
1
CH2), 43.6 (N
5
CH2), 52.1 (C(2)), 107.5 (C(3)ArC(4)), 110.4 (C(3)ArC(5)), 
126.4 (ArCH), 127.2 (ArCH), 127.4 (ArCH), 127.6 (ArCH × 2), 127.8 (ArCH × 2), 128.4 
(ArCH × 2), 128.5 (ArCH × 2), 128.6 (ArCH × 2), 128.9 (ArCH × 2), 137.9 (NCH2ArC(1)), 
138.1 (NCH2ArC(1)), 139.3 (C(2)CH2ArC(1)), 141.4 (C(3)ArC(3)), 154.4 (C(3)ArC(1)), 
170.9 (C(5)), 172.2 (C(1)); m/z (NSI
+
) 489 ([M+Na]
+
, 34%), 467 ([M+H]
+
, 100%); HRMS 
(NSI
+
) C30H31O3N2 [M+H]
+
 found 467.2326, requires 467.2329 (–0.7 ppm). 
(2S,3S)-N
1
,N
5
-Dibenzyl-2-methyl-3-pentylpentanediamide (33). Following the general 
procedure, 1-oxopropan-2-yl 4-nitrobenzoate 10 (67 mg, 0.30 mmol), (E)-1,1,1-trichloronon-
3-en-2-one (56 mg, 0.20 mmol), NHC precatalyst 11 (7.4 mg, 0.020 mmol) and Et3N (42 µL, 
0.30 mmol) in anhydrous CH2Cl2 (2.7 mL) at rt for 24 h gave a crude brown oil (˃95:5 dr). 
The crude was stirred in anhydrous CH2Cl2 (6.6 mL) with benzylamine (6.6 mL, 60 mmol) at 
rt for 16 h to give a crude orange paste (˃95:5 dr) that was triturated in Et2O to give the title 
compound (21 mg, 26%) as a white solid. mp 168–170°C; [α]D
20 +15.0 (c 0.40, CHCl3); 
Chiral HPLC AD-H (90:10 hexane : IPA, flow rate 1.0 mL·min
-1
, 211 nm, 40 °C) tR minor: 
5.3 min, tR major: 5.8 min, ˃99% ee; νmax (film, cm
-1
) 3287 (N–H), 1636 (C=O), 1541 (N–
C=O), 1535 (N–C=O), 1454; 1H NMR (400 MHz, CDCl3) δH: 0.86 (3H, t, J 6.8, CH3), 1.12 
(3H, d, J 7.0, C(2)CH3), 1.16–1.36 (7H, m, CH3(CH2)3 and C(3)CH
A
H
B
), 1.43–1.53 (1H, m, 
C(3)CH
A
H
B
), 1.95–2.07 (1H, m, C(3)H), 2.22 (1H, dd, J 13.9, 6.1, C(4)HAHB), 2.29 (1H, dd, 
J 13.9, 8.0, C(4)H
A
H
B
), 2.50–2.59 (1H, m, C(2)H), 4.39–4.44 (4H, m, NCH2 × 2), 6.14 (1H, 
t, J 4.8, N
5
H), 6.48 (1H, t, J 5.1, N
1
H), 7.23–7.35 (10H, m, ArH); 13C{1H} NMR (101 MHz, 
CDCl3) δC: 14.0 (C(2)CH3), 14.1 (CH3), 22.6 (CH3CH2), 27.3 (CH3(CH2)2CH2), 31.1 
(C(3)CH2), 31.9 (CH3CH2CH2), 38.7 (C(4)), 40.0 (C(3)), 42.1 (C(2)), 43.4 (NCH2), 43.5 
(NCH2), 127.4 (ArCH), 127.5 (ArCH), 127.7 (ArCH), 127.8 (ArCH), 128.7 (ArCH), 128.7 
(ArCH), 138.4 (NCH2ArC(1)), 138.6 (NCH2ArC(1)), 172.9 (C(5)), 174.7 (C(1)); m/z (NSI
+
) 
([2M+Na]
+
, 34%), 395 ([M+H]
+
, 100%); HRMS (NSI
+
) C25H35O2N2 [M+H]
+
 found 
395.2690, requires 395.2693. 
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